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THE ART OF BREAST IMAGING
At the Washington University Medical Center, radiologists
and technologists provide a lifesaving breast-cancer
screening program for women in the St. Louis area.

12THE.^LIABILITY OF MRI
A multicenter study is proving that magnetic resonance
imaging techniques can noninvasively determine the
malignancy or benignancy of adrenal masses.
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Radiation oncologists and cancer biologists combine efforts
to improve treatments for patients with cancer.
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The proposed overhaul of the U.S. health-care system
carries operational and cost-control challenges
for all medical fields.
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ON THE COVER:
For every 100,000 women in the U.S., 27 will die as a result of breast
cancer. Dr. Barbara Monsees, chief of the Institute's breast imaging
section, and a team of radiologists and technologists want to reduce
those numbers. Photography by Tim Parker.

SPOT NEWS
The Best
Doctors in
America
The results of a yearlong
survey are in, and the second
edition of The Best Doctors in
America has listed eight
Mallinckrodt Institute physicians as "the best and brightest" in the medical profession.
Based on an extensive nationwide poll of thousands of
medical specialists, the book
lists 7,200 of the highest rated
doctors nationwide, approximately 2 percent of the
nation's 350,000 practicing
physicians. Over 350 specialities are represented.
According to the book's
editors at the publishing
house of Woodward/White,
Inc., the listing is credible
because the evaluation of
the best doctors was made
by other doctors in the same
speciality.
MIR physicians and their
field(s) of expertise as
reported in The Best Doctors
of America are
■ Perry W. Grigsby, M.D.,
professor of radiology and
clinical chief of the Radiation
Oncology Center, Barnes Hospital — radiation oncology:
gynecologic cancer
■ Tom R. Miller, M.D.,
Ph.D., professor of radiology
— nuclear medicine: general
nuclear medicine
■ Robert J. Myerson,
M.D., Ph.D., associate professor of radiology — radiation
oncology: hyperthermia
■ Carlos A. Perez., M.D.,
professor of radiology and
director of the Radiation
Oncology Center — radiation
oncology: breast cancer, genitourinary cancer, gynecologic
cancer, and lung cancer

■ Henry D. Royal, M.D.,
professor of radiology and
associate director of the Division of Nuclear Medicine —
nuclear medicine: general
nuclear medicine, and radiation accidents and radiation
injury
■ Stuart S. Sagel, M.D.,
professor of radiology, chief
of chest radiology, and
cochief of body computed
tomography — radiology:
chest
■ Barry A Siegel, M.D.,
professor of radiology and
director of the Division of
Nuclear Medicine — nuclear
medicine: general nuclear
medicine
■ Todd H. Wasserman,
M.D., professor of radiology
and clinical chief of the Radiation Oncology Center, Jewish
Hospital — radiation oncology: lymphomas.

Evens Named
to ACR Office
In January, Ronald G.
Evens, M.D., director of the
Institute, was elected to a
two-year term as vice-chairman of the Board of Chancellors for the American
College of Radiology (ACR).
Evens, who in the fall of
1993 was renamed to a second term as the Board's secretary-treasurer, will assume
his new office in September
of 1994. The24-member
Board is the governing body
of the ACR, determining
policy standards for this
national organization of
more than 28,000
radiologists.

Researchers
Earn Whitaker
Foundation
Awards
P. Duffy Cutler, Ph.D.,
assistant professor of radiology, Division of Nuclear Medicine, and Ge Wang, Ph.D.,
assistant professor of radiology, Division of Radiology
Research, each received a
prestigious Biomedical Engineering Research Grant from
The Whitaker Foundation.
Cutler and coinvestigator
Ming Xu, M.S., received funding in the amount of $179,496
for his research project "Clinically Viable 3-D PET Imaging
of the Torso." Wang's
$166,731 grant was awarded
for his project on "Spiral CT
of the Temporal Bone." Coinvestigators for this grant are
Michael Vannier, M.D., and
Margaret Skinner, Ph.D., Division of Otolaryngology.
The Foundation is a
major source of funding for
research and education in biomedical engineering. Established in 1976 by U. A
Whitaker, founder and chairman of the board of the
world's leading producer of
electrical and electronic connecting devices, the Founda-

P. Duffy Cutler, Ph.D. (left) and
Ge Wang, Ph.D.

tion promotes research collaboration among engineers,
physical scientists, biologists,
and physicians for the
improvement of the quality of
medicine.
The Biomedical Engineering Research Grant Program was the first program
initiated by the Foundation.
The three-year awards were
designed to help establish a
scientific track for researchers
who are in the early years of
their career — doctorates
must have been received less
than eight years prior to submitting a grant application,
and medical-degree applicants may apply within seven
years following completion oi
their last residency.
Research projects must
address a significant biological or medical problem and
may target either the understanding of biological systems or improvements in
medical care. The grants are
highly sought after, with
more than 300 applications
submitted for the 103 grants
awarded in 1993.
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NINDS Funds
Study of
Parkinson's
Disease
There are close to one
million patients in the United
States and Canada who are
affected by the tremor, muscular rigidity, and abnormal
decrease in mobility and motor
function associated with
Parkinson's disease. These
symptoms are caused by the
degeneration of neurons deep
within the brain; the degeneration subsequently leads to a
deficiency of dopamine, which
acts as a neurotransmitter in
the central nervous system.
Symptoms can be treated with
an amino acid known as Ldopa, but the treatment causes
involuntary muscle contractions in many patients.
Consequently, effective treatment is limited.
As principal investigator,
Joel S. Perlmutter, M.D., associate professor of neurology
and radiology, received a
$1,349,590 grant from the
National Institute of Neurological Disorders and Stroke
to study the physiologic
causes of L-dopa-induced
involuntary movements and,
subsequently, to provide
improved drug therapy for
parkinsonian patients. Using
positron emission tomography
(PET) and magnetic resonance imaging (MRI), Perlmutter and his team of
researchers will assess
changes in the dopaminergic
pathways as well as changes
in regional cerebral blood
flow. Dopaminergic receptor
binding in vivo will be assayed
using PET methods.
Research team members
include Stephen M. Moerlein,
Ph.D., associate professor of
radiology and biochemistry;
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Richard D. Todd, M.D., professor of psychiatry; Lee W. Tempel, M.D., research instructor
in neurology; Juanita L. Carl,
M.S., research instructor in
neurology; and Mokhtar H. Gado,
M.D., professor of radiology.

New Guidelines Released
for Evaluating
Prostate
Enlargement

Conturo
Receives ASNR
Fellowship

Bruce L. McClennan,
M.D., professor of radiology
and chief of abdominal radiology, was the only radiologist on the national panel that
developed new guidelines for
the diagnosis and treatment
of benign prostate enlargement. Doctors are now urged
to use a more conservative
approach to evaluate this
common disorder that affects
50 percent of the U.S. male
population over the age of 60.
As informed participants,
patients are encouraged to
become more involved in
choosing a treatment
method. The guidelines were
released in early February by
the Agency for Health Care
Policy and Research, a division of the Department of
Health and Human Services.
With benign prostate
enlargement, the prostate
gland enlarges and restricts
urine flow. More severe
cases can lead to recurring
urinary-tract infections and
kidney damage. Also known
as benign prostate hyperplasia (BPH), the disorder is
usually treated surgically but
can be treated with medication or by physician follow-up.
According to McClennan, the new guidelines may
reduce the cost of diagnosis
and treatment by advising
physicians to use simple,
inexpensive tests to evaluate
potential BPH and to perform additional tests only if
necessary.

E. Mark Haacke, Ph.D.

Thomas E. Conturo,
M.D., Ph.D., assistant professor of radiology, Division of
Radiology Research, received
the 1993-1994 American Society of Neuroradiology
(ASNR) Fellowship in Basic
Science Research. The fellowship is awarded annually
to a young investigator who
is or has been working under
the direction of a senior
member of ASNR. Conturo's
mentor is Daniel K. Kido,
M.D., professor of radiology
and chief of the Institute's
neuroradiology section.
Supported by a $35,000
grant from Berlex Imaging,
the one-year fellowship was
established in 1986 by ASNR
as a means to stimulate the
scientific development of
promising young researchers
and to assist them in establishing careers in academic
radiology. Conturo received
the ASNR fellowship for his
proposed research on "Mechanisms of the Phase Enhancement Effects of BolusInjected Paramagnetic Contrast Agents and Applications
in Quantitative Cerebral
Blood Volume and Flow
Imaging."

Haacke
Heads SMR
As of January 1, E. Mark
Haacke, Ph.D., professor of
radiology and director of MR
physicis, Division of Radiology Research, became the
first president of the newly
formed Society of Magnetic
Resonance (SMR), a merger
of the Society of Magnetic
Resonance in Medicine and
the Society for Magnetic
Resonance Imaging.
Haacke, the 1991-1992
president of the Society for
Magnetic Resonance Imaging, was instrumental in
facilitating the merger. He
served as a member of the
Joint Merger Evaluation
Committee that worked out
the technical details for
establishing SMR. Since
September of 1993, Haacke
has been interim president
and stepped down at SMR's
meeting in Dallas on March 7.
An international scientific association, SMR is comprised of over 3,600
clinicians, physicists, engineers, and other scientists
who are involved in the clinical and research applications
of magnetic resonance imaging techniques. The Society
provides a communication
link among those clinicians
and scientists as well as
channels for continuing education in the field of magnetic resonance.

SPOT NEWS
Royal to Advise
MIR Alum
Delivers Tolmach on Radiation
Experiments
Lecture
As the first graduate student to work with Professor
Leonard Tolmach, Dr. Robert
Phillips was involved in the
development of the mitotic collection method for obtaining
synchronous populations of
mammalian cells. This
research provided the basis for
future breakthroughs in studies on irradiated cell survival
and cellular repair.
Phillips, guest speaker for
the Second Annual Tolmach
Lecture, has focused his
research on the effects of drugs
on radiation sensitivity during
the cell cycle. His talk concerned "The Role of the
Retinoblastoma Gene in Normal Growth and Development."
The Tolmach Lecture was
established in 1992 in memory
of renowned scientist Leonard
J. Tolmach, Ph.D., professor
emeritus of radiation biology
in radiology, who died on
November 26, 1991. The lecture is presented in conjunction with the Annual
Midwestern Regional Radiation Research Meeting held
annually in November.
Robert Phillips, Ph.D.

Henry D. Royal, M.D.,
professor of radiology and
associate director of the Division of Nuclear Medicine, was
appointed by President Clinton as a member of the Advisory Committee on Human
Radiation Experiments. The
committee will investigate the
ethical and scientific history
of ionizing radiation experiments conducted from 1944
to mid-1974.
The President's action
was prompted by allegations
made in November of 1993 by
a newspaper reporter in New
Mexico, stating that patients
who were uninformed about
the risks of radiation exposure were injected with plutonium during experiments in
the 1940s. Although the
research had been conducted
according to scientific investigation guidelines for that
time, Department of Energy
Secretary Hazel O'Leary recommended that a full investigation be made.
After a review of the
experiments, the Advisory
Committee will set ethical

and scientific criteria for evaluating the experiments in
question and will determine if
the testing was in compliance
with those standards. The
Committee also will recommend policies to ensure that
current human radiation
experiments are consistently
conducted according to those
set standards.
The Advisory Committee's final report will be made
to the Human Radiation Interagency Working Group, comprised of the secretaries of
Energy, Defense, Health and
Human Services, and Veterans
Affairs; the Attorney General;
the Administrator of the
National Aeronautics and
Space Administration; the
Director of Central Intelligence; and the Director of the
Office of Management and
Budget.
Royal's expertise in radiation exposure has earned
international acclaim. At the
request of the International
Atomic Energy Agency
(IAEA) and in cooperation
with the former government
of the Soviet Union, Royal
performed an in-depth study
of illnesses attributed to the
1986 nuclear reactor explosion in Chernobyl. He was the
co-leader of the IAEA's medical, effect team that travelled
to Chernobyl in 1990. They
conducted a health survey of
inhabitants from both contaminated and noncontaminated
villages to determine the incidence of potential radiationrelated illnesses.

Osteoporosis:
A Possible
Link to Dental
Health
Charles F. Hildebolt,
D.D.S., Ph.D., associate professor of radiology, received a
National Institute of Dental
Research grant to investigate
whether osteoporosis can
result in loss of bone supporting the teeth.
The 150 women participating in the study will
receive free-of-charge
■ annual dental examinations, cleanings, and X rays;
■ calcium tablets;
■ physical examinations
and blood chemistry tests;
■ annual examinations
for osteoporosis; and
■ mammograms, pap
smears, and endometrial
biopsies (based on medical
history).
Criteria for study
participation:
■ last menstrual period 24
months prior to start of study,
■ good health,
■ no consumption of
drugs that might affect bone
matter, and
■ have at least 10 natural
teeth.
The study is conducted u i
collaboration with The Jewish
Hospital Department of Dentistry and Washington Univer
sity's Department of
Medicine, Division of Bone
and Mineral Diseases. For
more information, call Mary
Dotson, Jewish Hospital Der
tal Group, 314-454-5507.
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Most Prolific
Reviewers
In the February, 1994
issue of Radiology, Stanley S.
Siegelman, M.D., editor, paid
tribute to the "corps of dedicated, unpaid reviewers" in a
listing of the most prolific
reviewers of manuscripts submitted to the journal. According to Radiology's statistics,
1,010 scientists and physicians
reviewed 17,974 manuscripts
over the four-year period of
July 1,1989, through June 30,
1993. There were 18 MIR faculty members among the 174
reviewers who each prepared
35 or more reviews:
■ Dennis M. Balfe, M.D.
■ Jeffrey J. Brown, M.D.
■ Michael D. Darcy, M.D.
■ Ronald G. Evens, M.D.
■ E. Mark Haacke, Ph.D.
■ Jay P. Heiken, M.D.
■ Marshall E. Hicks, M.D.
■ Bruce L. McClennan, M.D.
■ William D. Middleton,
M.D.
■ Scott A. Mirowitz, M.D.
■ Barbara S. Monsees, M.D.
■ Daniel Picus, M.D.
■ Stuart S. Sagel, M.D.
■ Barry A. Siegel, M.D.
■ Marilyn J. Siegel, M.D.
■ Michael W. Vannier, M.D.
■ Anthony J. Wilson, M.B.,
Ch.B.
Cited for their consistently high quality of reviews,
James A Brink, M.D., assistant
professor of radiology, and
Scott A Mirowitz, M.D., associate professor of radiology
and radiologist-in-chief at Jewish Hospital, each received
Radiology's "Editor's Recognition Award for Special Distinction in Reviewing."
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RTOG Clinical
Trials
As a member of the
national cancer research organization Radiation Therapy
Oncology Group (RTOG),
MIR's Radiation Oncology
Center is participating in many
clinical trials, providing treatment for patients with cancer.
According to Bahman Emami,
M.D., Washington University's
RTOG principal investigator,
many patients treated during
clinical trials for cervical,
esophageal, anal canal, lung,
and prostate cancer have
remained cancer free. Many
of today's standard cancer
treatments are based on
results of past clinical trials.
Less than 5 percent of
adult cancer patients are
treated as part of research
studies. "If more adults participated in clinical trials, we are
confident that the overall survival rates would increase,"
says Emami. For further
information, call Emami at
314-362-8525.

CDS Improving
Detection of
Ovarian Cancer
Ovarian cancer annually
affects more than 20,000
women in the United States,
and more than 50 percent of
those women will die as a
result of the disease. There is
no screening examination for
ovarian cancer as there is the
pap smear for cervical cancer
or the mammogram for breast
cancer.
According to Arthur C.
Fleischer, M.D., guest speaker
for The First G. Leland Melson
Visiting Professorship and
Lecture on November 11,
recent studies have provided
good results in determining
malignancy or benignancy in
pelvic masses by using color
Doppler sonography (CDS).
In Fleischer's experience, CDS
combined with CA-125 (a
blood test for identifying ovarian cancer) produces a 91 percent diagnostic rate as
compared to 82 percent with

Arthur C. Fleischer, M.D., (left) and
Bruce L McClennan, M.D.

CA-125 alone.
Known for his expertise
in sonographic imaging, Fleischer, professor of radiology
and radiological sciences and
professor of obstetrics/gynecology at Vanderbilt University School of Medicine, said,
"It's difficult to have a high
level of confidence based on
morphology. With the CDS
approach, the physician can
go from morphology to looking at whether or not there is
a tumor. CDS also is a useful
tool for determining patients
who may not need surgery."
The Melson Visiting Professorship and Lecture was
established in 1993 in honor
of G. Leland Melson II, M.D.,
who was professor of radiology and chief of the Institute's
clinical ultrasound at the time
of his death on November 10,
1992. He was instrumental in
introducing color Doppler
sonography to the Institute.

An active member of breast-cancer screening committees at the city and

state levels, Barbara Monsees, M.D., has been instrumental in developing

the Institute's consistently high-quality breast imaging service.

BARB

ccording to statistics reported by the American Cancer
Society, every 15 minutes three women develop breast cancer and
one woman dies as a result of the disease. Second only to lung
cancer, more women in the United States die from breast cancer
than from any type of cancer. These are disturbing facts, but the
numbers of lives lost can be reduced. Mammography, a breastcancer screening test, can detect cancer even before a mass can
be felt. When breast cancer is diagnosed in its early stages, the
prognosis is markedly improved: The death rate from breast
cancer can be reduced by at least 30 percent for women who are
screened as compared to a control group of
women who are not screened.
Across the nation, mammography is

In 1986,
MIR
launched

being recognized

the area's
first
mobile

for the critical
role it plays in women's health care.
The number of women taking advantage of routine screening mammography is increasing, and this lifesaving test is on its way to becoming
a routine part of medical checkups.

unit.

ART
HSEASlMQNG
MIR's BREAST
IMAGING SECTION
^T^n August of 1993, Ronald
^^W G. Evens, M.D., director
of Mallinckrodt Institute,
established a separate breast imaging section. Originally a part of
musculoskeletal radiology, the new
section now acts independently.
Barbara S. Monsees, M.D.,
chief of breast imaging, heads up a
six-member clinical team: Drs.
Premsri Barton, Tracy Roberts, and
Peter Shile, and a mammography
fellow at Barnes Hospital; and Dr.
Lawrence Kotner at Jewish Hospital. These radiologists work closely with a staff of mammography
technologists: Sharon Albertina,
R.T., manager of radiology, who
directs the entire technical staff;
Roberta McQueen, R.T., supervisor

of the mammography technologists
at Barnes and Jewish hospitals;
Linda Schubert, R.T., supervisor at
Barnes West Hospital; and Christine Focht, R.T., supervisor of the
mobile mammography staff. The
radiologists and technologists are
a team with a common goal: saving lives through the early detection of breast cancer while
providing quality care for women
with symptoms that necessitate
breast imaging.
For women with no symptoms
of breast cancer, screening mammography is performed on the
mammography mobile unit, at the
Mammography Screening Center,
and at the Jewish Hospital mammography service. Patients with
clinical problems, breast implants,
or a prior history of breast cancer
can have diagnostic mammography
performed at the Breast Diagnostic
Center at Barnes or at the Jewish
Hospital mammography service.
Collectively, nearly 150 mammograms are performed daily.
With such a high volume of
patients, an effective program
must include teamwork and a
mutual respect among radiologists
and technologists. Monsees points
out that a key factor in the success
of the program is that all technologists work exclusively in mammography, and are either specialty
certified as mammographers or are
in the certification process. As a
result of the mammographer's
familiarity with the technique, consistently high quality images are
obtained.

If images are poor, some cancers may go undetected. In the
Breast Imaging section, a series of
checks and balances insures that
achieving quality is a daily routine.
Monthly meetings among Monsees;
the radiology manager and supervisors; Michael Ward, R.T., M. Ed.;
Barnes quality assurance manager;
and Michael Ter-Pogossian, Ph.D.,
and Glenn Fletcher, Ph.D.,
Mallinckrodt Institute medical
physicists, address policies, problems, and solutions.
"We not only review and interpret standards, we make certain
that all standards are met and documented. What we see as necessary to achieve quality films is
accomplished," says Monsees.
Diane Radford, M.D., Washington University assistant professor
of surgery and Barnes Hospital
breast surgeon, frequently uses the
services provided by the Breast
Imaging section. "I rely on them
very heavily," she says. "The quality of mammography films and
interpretations are very important.
I can't use too many superlatives
to describe their work." □
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MIR RADIOLOGISTS CALL FOR A
RADIOLUCENT BREAST IMPLANT FILLER
y^^ugmentation mammoAw -plasty, a breastC_^/ %^/ enlargement
procedure using a sealed silicone
gel- or saline-filled prosthesis, has
been available to women since the
1960s. Since then, between 1 and 2
million women have undergone
breast augmentation, making it one
of the most frequently performed
procedures in plastic surgery.
Weekly, as many as 10 women
with augmented breasts come to
one of the Medical Center's mammography facilities. Although
screening mammography is the
best diagnostic test for detecting
clinically occult tumors in the
unaugmented breast, implants are
opaque to X rays and block 22 to
83 percent of the breast tissue.
In an attempt to better visualize the overlying breast tissue,
mammographers obtain special
views, called "pinch" or displacement views, where the breast
tissue is pulled forward from
the implant and selectively compressed, in addition to the standard views. But even these do
not afford the entire breast to be
visualized.
In 1987, Mallinckrodt Institute
radiologists decided there had to
be a better way. Prompted by
Louis Gilula, M.D., chief of musculoskeletal radiology, a search
began for a new, radiolucent
breast implant filler. Gilula, Monsees, and former colleague Dr.
Judy Destouet, asked Leroy
Young, M.D., a Washington University plastic surgeon, for his help in
contacting implant manufacturers
for collaboration on the research.
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When outside suppliers expressed little or no
interest in the project, the
research team went to
John Eichling, Ph.D., the
Institute's radiation safety
officer. Pulling out the
textbooks, Eichling calculated the effective atomic
number for breast tissue,
based on the ratio of glandular fat in a normal
breast.
The atomic number of
various substances is the
chief determinant of the final
image's character. Substances with
high atomic numbers, such as the
silicone gel used in most implants,
are more opaque and block X rays
almost as much as bone does. This
opacity causes all tissue overlying
the implant to be hidden on a mammogram. An implant filled with a
material similar to the low effective
atomic number of breast tissue was
clearly needed. Eichling's search
for naturally-occurring materials
identified several possible candidates, including triglycerides such
as peanut and sunflower oils.
Subsequently, a medical manufacturer provided experimental
implants and testing began: the
implant shell alone; shells filled
with either peanut oil or sunflower
oil; shells filled with saline or silicone gel. X rays taken of each of
the implants, which overlay a phantom simulating breast cancer

masses and microcalcifications,
provided positive results. The
implants containing peanut oil or
sunflower oil were radiolucent;
the silicone-gel and saline fillers
completely obscured mammography while the implant shell had
little or no effect on resolution.
With the help of AAV Company, which investigates commercial outlets for Washington
University research, Destouet,
Eichling, Gilula, Monsees, and
Young now hold the patent for a
radiolucent breast implant filler.
Lipo-Matrix, a Palo Alto, California-based company formed
through the cooperative efforts of
AAV, is developing the implants
and designing appropriate clinical
trials. Research is in the preclinical
stage, awaiting FDA approval. □

ART
BREASTMONG
SCREENING GUIDELINES
CONTROVERSY
/W recent National Cancer
t^/C/Institute (NCI) conference
concluded that there is no proven
benefit in annual or biannual raammography screening for women
under 50 years of age. In a highly
controversial act, the NCI removed
its recommendation for routine
screening mammography for
women under age 50. The American Cancer Society (ACS), the
American College of Radiology, and
the American Medical Association
continue to recommend mammography screening for women over
age 40. Although the NCI advises
women to seek the advice of their

FACILITY
ACCREDITATION
(0^"here are currently 12,000
mammography units in
the country. More than 50 percent of those units, including
those at Barnes and Jewish hospitals and on the mammography
van, participate in voluntary
accreditation through the American College of Radiology. In
October of this year, the Mammography Quality Standards Act
(MQSA), under the control of the
Food and Drug Administration,
will require that all mammography facilities be accredited
For accreditation, mammography facilities must use dedicated mammography equipment,
adhere to quality assurance programs, hire qualified technologists
and physicians, and submit images
for review. Noncompliance could
result in a fine of up to $10,000 for
each failure or for each day a
facility is noncompliant. □
10

personal physicians, its "Updating
the Guidelines" report recommended mammography screenings
for women 50 and older at one- or
two-year intervals.
"It's confusing to women. If
experts in the American Cancer
Society and NCI can't agree on
guidelines, how will women decide?
It leaves room for a lot of confusion
and rightly so," says Monsees. "I
fear that women will not be as compliant with ACS recommendations.
A consequencewill be that some
breast cancers will wait years to be
detected, until they can be felt, and
at that point it may be too late."
NCI's report was based on an
evaluation of eight studies conducted during the last 30 years.
Many experts point out that the
studies were flawed and do not
have the statistical power to provide proof even if it exists. Critics
of the NCI lashed out that the recommendation was impacted by cost
factors.
"I think the NCI's decision is
important because it will eventually
impact reimbursement for mammograms," Monsees says. "If the NCI
doesn't recommend screening
under age fifty, this will create a
two-tiered system — women
under fifty years of age who can
afford to have screenings, and those
who can't"
Until the guidelines for screening mammography are changed,
Mallinckrodt Institute radiologists
will continue to follow these
recommendations:
■ Ages 40 to 49 — Mammogram every one to two years,
based on risk factors.
■ Age 50 and up — Mammogram every year.
Monsees recommends that
women over age 40 have yearly
mammograms. "Younger women
tend to have faster growing tumors.
For this reason, two years between
screenings may be too long." □

DR. CELETTE
SUGG SKINNER
I^T^Pne ability to tap into
^—*^F Mallinckrodt Institute's
t^S
data base of 86,000
mammography screenings, which
have been collected for over seven
years, is like mining for gold to
Celette Sugg Skinner, Ph.D.,
research instructor in radiology.
Joining the breast imaging
research team last fall, Skinner specializes in public health and health
behaviors but has a special interest
in mammography screening utilization. Skinner's research of the
effect of physician-to-patient message tailoring, conducted when she
was at the University of North Carolina at Chapel Hill, appeared in the
January issue of the American
Journal of Public Health. Interest
in the topic has captured national
media attention.
"We knew that doctors' recommendations for screening were key
predictors in whether patients followed through and had a mammogram," says Skinner.
"We wanted to determine
whether printed, tailored recommendations addressing women's
specific screening and risk status
and their perceptions about breast
cancer and mammography made a
difference," she adds.
The results were that tailored
physicians' recommendations did
affect whether hard-to-reach populations had mammograms. More
African-Americans and low-income
women who received tailored messages went on to have mammograms than those who received a
standard letter.
With a master's degree in communications and having worked
professionally in market research,
Skinner's perspective in applying
basic marketing techniques to
MALLINCKRODT INSTITUTE OF RADIOLOGY

health care has made an impact.
"The idea is to address issues of
importance to individual women,"
she says.
The goal of her research was to
examine how to get women to continue coming for mammograms by
first understanding their beliefs and
perceptions about breast cancer and
mammography screening. Once
behavior predictors are known, it is
possible to develop a means of intervention in public health, says Skinner. This can be accomplished
simply by an informational brochure
or a mass screening program.
Working with Maria Schmidt,
M.D., and Thomas Pilgram, Ph.D.,
Skinner's goals for the Institute's
data base are to explore whether
factors such as the source of mammogram referral or women's experiences with
the possibility of abnormal
mammographic findings affect
whether they
return as
often as they
should for
screenings.
"Many
studies look
at these
issues but
don't have
the years of
data we have
here. It's an Celette Sugg Skinner, Ph.D.
interesting
and important question — do
women have different screening patterns because of their experiences?
This will help us figure out how to
get patients to come for screenings,"
says Skinner.
While Skinner mines the data
base for gold, somewhere up the
road patients may reap the rewards
of participating in a regular mammography screening program. □
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DR. PETER SHILE
eter E. Shile, M.D.,
assistant professor of
radiology, comes to
Mallinckrodt Institute from the University of Pennsylvania where he
completed fellowships in breast
imaging and medical informatics.
While interviewing for positions in
breast imaging, he was particularly
impressed with the quality care
offered to women at the Institute's
breast imaging services. He finds
both the Breast Diagnostic Center
and the Mammography Screening
Center to be "extraordinarily comprehensive and efficient."
"I work with top-of-the-line
equipment, an outstanding group of
radiologists, and
suberb technologists
and support staff," he
comments. 'This service offers high quality exams and
thorough patient
tracking and followup.
In addition to his
clinical training, Shile
brings training in
radiological informatics to MIR's new
breast imaging section. He defines his
research interests as
"the application of
computers to information handling in
radiology." A major portion of
Shile's research training during his
University of Pennsylvania fellowship involved a three-year, $5 million National Institutes of Health
study to evaluate the effectiveness
of a Picture Archiving and Communications System (PACS). His work
focused on evaluating the impact of
PACS on the transmission of radiological information to intensive care
units.

Peter E. Shile, M.D.

"Electronic communication of
radiological information will almost
certainly lead to more efficient
patient care and, as a result, will play
an important role in medicine as
health-care reform advances," says
Shile.
One of the Institute's attractions
for Shile was the large data base of
information that has been collected
for mammography screening. He
and Barbara Monsees, M.D., section
chief of breast imaging, hope to link
this data base with the tumor registries in Missouri and Illinois -a
project that, according to Shile,
would provide a complete source of
data for doing outcome studies.
The Electronic Radiology Laboratory (EEL), headed by G. James
Blaine, D.Sc., was another of the
Institute's attractions for Shile: "The
ERL is a world-class center of expertise and is at the forefront of implementing and developing technologies
for acquiring, storing, transmitting,
and displaying radiological images in
digital format." Through collaboration with ERL scientists, Shile hopes
to improve diagnostic accuracy in
mammography by developing new
ways to process and display image
information in mammograms. □
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ne of the first magnetic resonance imaging
(MRI) scanners in the world arrived at
Mallinckrodt Institute in the summer of
1983. At that time, MRI was the newest of
the imaging modalities, and Institute scientists were eager to investigate the technology. During the past 10
years, MRI has proven to be a reliable tool for clinical and research
applications.
Under the direction of Jeffrey J. Brown, M.D., chief of the MRI
section, the Institute now is leading a multicenter study that may
provide patients who have adrenal masses with a noninvasive means
for determining if the lesion is benign or malignant. Institute faculty
are collaborating with researchers and clinicians from Georgetown
University Medical Center, the University of North Carolina at
Chapel Hill, New York University, the University of California at Los
Angeles, and the University of Alabama at Birmingham. And according to Brown, the technique is working extremely well.

Situated just above the kidneys,
the adrenal glands are common
sites for both benign and malignant lesions. Generally, clinicians
have two options when an adrenal
mass is discovered: biopsy under
computed tomography (CT) guidance
or following the patient while performing interval imaging studies.
The lesion often cannot be
ignored because of possible malignancy, says Brown, but the physician
may be hesitant to pursue aggressive
diagnostic methods, such as biopsy,
because the majority of the lesions
are benign.
Although adrenal lesions usually
are discovered incidentally on CT
scans, computed tomography has limited capabilities in characterizing
these lesions. Histologically, adrenal
lesions contain water and a large
amount of fat, roughly 40 percent.
Magnetic resonance further distinguishes soft tissues: muscle, tendon,
ligament, articular and fibroid cartilage, fluid, blood, flowing blood, and,
most importantly in the case of
adrenal lesions, fat.

Using no ionizing radiation, magnetic resonance
imaging is based on
interactions
between a large
magnetic field in the
imaging equipment
and the atoms in the
human body. The
imaging data in MRI
is detected in a manner similar to the
signal received by
an ordinary radio
with a receiver coil
or antenna. The
data is then
processed by computer to produce the images.
Brown points out that as far back
as 1986 researchers were testing
whether MRI could diagnose malignancy in adrenal lesions but because
of small study population and older
imaging techniques, the studies did
not produce reliable results. "In the
end, MR lost credibility for this type
of study," he says.

As an MR physicist, Debiao Li, Ph.D., develops
data acquisition techniques so that magnetic resonance images contain high resolution, less image
artifacts, and the best possible signal and contrast.

n article authored by
researchers at Thomas Jefferson University Hospital and
Jefferson Medical College, which was
published in the November 1992 issue
of Radiology, renewed Brown's interest in MR imaging of the adrenal
glands. The article advocated diagnosis of adrenal lesions by chemical
shift, or opposed-phase, imaging. By
using this method, the imaging signal
intensity from tissues is derived by
subtracting the fat signal from the
water signal. The article looked
promising, says Brown. And since the
Institute had joined the Body MR
Research Group, comprised of academic institutions that use magnets
manufactured by Siemens Medical
Systems, he would have the opportunity to study a larger population that
could produce improved results.
Under the direction of Jeffrey Brown, M.D., the Institute's magnetic resonance imaging section includes the
laboratory of clinical radiology, which provides for the
coordination and support of all clinical diagnostic
research programs. Brown also is program director for
the Institute's research residency program.
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rrown also had another ace in
the hole — MR Physicist
Debiao Li, PhD., assistant professor of radiology, rounded out
Brown's research team of Joseph A.
Borello, M.D., assistant professor of
radiology, and Kevin L. Shady, M.D.,
MR fellow. In August of 1993 a group
of MR physicists, led by E. Mark
Haacke, PhD., professor of radiology,
was recruited from Case Western
Reserve University in Cleveland in
anticipation of the construction of the Institute's new imaging
research center. The
center is slated for completion in November of
1994. The facility will be
one of the best equipped
centers worldwide
where research will
focus on the development and application of
advanced MR techniques. These scientists
have a broad range of
research interests, including brain
functional imaging, high resolution
MR angiography, MR cardiopulmonary imaging, breast MR, fast imaging, general MR physics, and image
reconstruction methods.
According to Li, the physicist's
role in basic science research relates
to the study of the fundamental theory and mechanism behind MRI. In
clinical research, the physicist develops new MR techniques and modifies
current techniques in order to meet
the clinicians'needs. In the adrenal
gland study, Li modified imaging techniques and optimized imaging parameters so the diagnostic criteria could
be achieved. He was able to obtain
the best signal and contrast by manipulating the system software and oversaw image quality control and image
evaluation.
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Figure 1 (left): Benign adrenal adenoma.
(A) In-phase images shows a right adrenal
mass (arrow) that is approximately isointense with the liver. (6) On the opposedphase image, the mass (arrow) is markedly
hypointense as compared to the liver.
Figure 2 (below): Adrenal metastasis. (A)
In-phase image shows a left adrenal mass
(arrow) with a signal intensity similar to
that of the spleen. (B) Adrenal mass
(arrow) remains equal in intensity with
the spleen on the opposed-phase image.
The black outlines around the adrenal mass
and other structures are due to signal loss at
fat/water interfaces and are characteristic of
opposed-phase images.

^ome of the techniques are
^^^specific to the scanners,"
,
%^says Li. "The companies
are continuously improving both the
hardware and the software for their
scanners. In order to achieve successful research, it is important that MR
physicists establish a good working
relationship with companies like
Siemens."

The team members have
examined 34 lesions at the
Institute as well as 20 from
the other institutions participating in the study. To date,
the group's success rate for
identifying benign adrenal
lesions is nearly 100 percent
— on one scan, the lesion
was too small to make a definitive
diagnosis; on another, metal from a
surgical clip obscured the image.
Brown plans to include 200 patients,
collectively, in the study.
"Our goal is to have a reliable
technique so that when an adrenal
lesion is found, the patient won't
need to go to biopsy or need to wait
and see and worry. We can produce
a reliable answer with MR," Brown
says. □
MALLINCKRODT INSTITUTE OF RADIOLOGY
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Improving
CANCER
THERAPY
he Mallinckrodt Institute of Radiology
has long recognized that the birth of
new treatment and diagnostic tools
requires the marriage of researcher and
clinician. The year-old Human Tumor
Cell Biology Program, which brings together cancer biologists and
radiation oncologists, represents another such MIR union. Among the
results of this potentially fruitful partnership are tests to predict more
accurately how human tumors will respond to different therapies.
Heading the program are researcher Joseph L. Roti Roti, Ph.D.,
associate director of the Radiation Oncoloy Center and chief of the
cancer biology section, and clinician Todd H. Wasserman, M.D.,
chairman of the Radiation Oncology Center at Jewish Hospital. Participating in the cooperative venture are the entire cancer biology
staff and clinicians from the Institute's Radiation Oncology Center
and from Washington University School of Medicine's departments

BY CLIFF FROEHLICH

of Surgery and Otolaryngology - Head and Neck Surgery.
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The seed for the joint project
was planted by the biologists. "It originated," Roti
Roti explains, "because the cancer
biology section had a program in
place to better understand the way
certain cellular structures and functional components relate to how
tumor cells respond to therapeutic
agents." Out of this project grew the
Human Tumor Cell Biology Program, a broad-based approach to
developing predictive assays: tests
to measure, in Roti Roti's words, "a
particular function that may exist in
a tumor."
The program is working on a
multiplicity of assays, says Roti Roti:
"We're investigating four or five different DNA damage-and-repair
assays, also assays for proliferation
and for certain types of ontogenic
transformation, or gene mutation.
There are ten different protocols
already written."
Some of these assays, of course,
will prove more practically applicable than others. In the best case scenario, an assay will have real clinical
utility. "An assay could develop into
a test that clinicians would routinely
use, a test similar to the estrogenreceptor assay commonly used in
breast cancer," says Wasserman. "If
a patient had, say, X value on the
test, then that would indicate a
poorer or better prognosis, and
treatment might be altered. Certainly outcome can be predicted,
and sometimes the option of altering
treatment may improve that outcome."

The program's broad scope
—its simultaneous exploration of many assays — is
one of its primary distinguishing features. According to Roti Roti, other
trials take an assay and run with it.
Although MIR doesn't necessarily
have the definitive test, the
researchers are looking for assays
that ought to predict response based
on biological principles. "Ours is a
systematic approach," he says.
"There are investigators who are
conducting a trial of one assay, and
they're studying it in hundreds of
patients," Wasserman continues.
"We've opted to stick to a more
broad development of assays, not
broad testing of a single assay.
When we come up with an assay
that we feel is really worthwhile,
we'll be very happy to run with it vis
a vis RTOG [Radiation Therapy
Oncology Group, the radiation
therapy national research groupJ."
Wasserman points out that the
Institute's methods for developing
an assay are similar to those followed by companies. And, in fact,
some of the work may end up being
proprietary or patented or applicable to outside support.
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"This project is a
way to translate
cancer biology into
clinical trials and
eventually clinical
practice."
Potentially beneficial though
the tests may prove, both
Wasserman and Roti Roti
emphasize that the development of
new assays is not the sole benefit to
be derived from the Human Tumor
Cell Biology Program. The biologists also gain additional information about tumor biology,
streamlining techniques, and different ways of detecting important
prognostic variables.
One of Roti Roti's particular
goals for the project is the scientific
enhancement of future clinical trials.
One of the differences Roti Roti
hopes to achieve is the development
MALLINCKRODT INSTITUTE OF RADIOLOGY
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Left: Joseph L. Roti Roti, Ph.D. professor of radiology,
also carries joint appointments at Washington University as professor of cell biology and physiology and
professor of biochemistry and molecular biophysics.
Below: Todd Wasserman, M.D. is a recognized authority in the treatment of Hodgkin's disease and was
instrumental in introducing to the St. Louis region the
concept of stereotactic radiotherapy of brain tumors.

of a hypothesis-driven clinical trial.
Most clinical trials now are more
empirical, he says, citing as examples the failed hyperthermia and
hypoxic-sensitizer trials.
In these trials, no difference was
seen between patients who were
given an experimental treatment and
those who were not. "So we
achieved what is termed 'null
hypothesis.' The patients weren't
harmed by it, but the treatment had
no effect," Wasserman explains.
"One of the problems was that with
such a heterogeneous population,
the potential of seeing an effect was
washed out. What we'd like to have
seen was the ability to define in
advance which patients would and
FOCAL SPOT, SPRING, 1994

would not benefit. Maybe then the
trial would have been positive."
Researchers hypothesize that
the hypoxic-sensitizer trial may have
failed because of the heterogeneous
population, or because human
tumors do not have the type of
hypoxic-cell population tested, or
because in human tumors
MM those hypoxic cells will not
respond in the same way as
rodent tumors respond. They
also believe that the hyperthermia trial may not have
been successful because the
tumor was not heated or
because human cells are
more resistant to heat than
are rodent cells.
With information
provided by the
Human Tumor Cell
Biology Program, future trials
should stand a better chance
of success. "We'll try to find
molecular markers," says Roti
Roti. "For example, in hyperthermia, we know that certain
proteins are present when
cells are more resistant to
heat. We might ask the question of whether those proteins are present in the
human tumor population that
would figure into such a trial.
Those kinds of questions are what
this program is attempting to solve."
Another of the unique aspects of
the Human Tumor Cell Biology Program is hinted at in its name: its use
of human tumors. "For the most
part, biology research has traditionally been conducted using mouse
tumors," Wasserman says. "There is
a great deal of sameness between a
human tumor and a mouse tumor.
That sameness is good from the
biologist's point of view because it
affords the ability to work up an
assay very cleanly, but it's not clean
necessarily in the reality of life."

"An assay could
develop into a test
that clinicans would
routinely use... ."
Roti Roti amplifies: "There are
whole fields of treatment and modality development that are compromised by the fact that all the work
done previously was on mouse
tumors. In hyperthermia, for example, the way rodent cells cope with
heat stress is very different from the
way human cells cope. Therefore,
when a clinical trial is developed
based on radiation-biology experience, all of which is obtained from
rodent cells and systems, it runs the
risk of having a flawed rationale."
ut Wasserman is quick to
. point out that work with
human tumors by no means
devalues or eliminates experimentation with rodents. "Tumor biology
on rodent cells will continue," he
says. "There are certain aspects in
development for which the
researcher cannot be dependent on
human tumors to do the work."
The project heads are pleased
with the progress of the project thus
far. "I'd say our goal in the first year
or two was to get assays up and running," says Wasserman. That
accomplished, much still remains to
be done. "This project is a way to
translate cancer biology into clinical
trials and eventually clinical practice," adds Roti Roti. "The project's
in phase one of the translation
process." □
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Payment for health care in the U.S.
has changed rapidly during the
1980s, with the changes often
identified

by

three-letter

acronyms such as HMO, PPO, DRG, and KVS.
Changes are likely to be even more rapid and
fundamental in the next few years. Managed
care and managed competition are the terms
principally being used to describe these changes.
In this overview, the goal is to present briefly the
changes that have occurred, the changes we are
likely to see, the implications of these changes for
radiologists, and how radiologists can respond

The Changing World
of Health Care Payments
Conventionally, indemnity insurance payment as
we knew it is already on the way to oblivion,
with managed care replacing it. Managed care
today comes in three broad forms that embody increasingly radical departures from the old model:
■ What we'd call managed-conventional coverage in
which patients or their physicians must obtain
prior authorization for hospitalization and (increasingly) for expensive outpatient services, such as
surgery or MRI.
■ PPOs (preferred provider organizations), alternatively known as point of service (POS) arrangements. Under these, insurance typically pays in
full, according to a negotiated fee schedule, if a
patient uses a network or preferred physician or
hospital but pays only 80 percent if the patient uses
an outside provider. Purportedly, these networks
were organized by selecting practitioners who are
efficient in their practice patterns (use few tests,
are slow to recommend surgery, etc.) and modest
in their fees. In most cases, PPOs have tended to
be a vehicle for obtaining discounted fees with little attention paid to practice patterns.

most effectively.
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■HMOs (health maintenance organizations), in
which a patient has no coverage unless he or she
uses a doctor or hospital that is part of the HMO.
HMOs come in two basic forms: the group or staff
model in which salaried physicians are involved
essentially full time with HMO patients, and the
more open IPA (individual practice association), in
which physicians maintain their own practices and
see HMO patients as only part of their workload.
The change to managed care is fueled by a desire
to attack the problem of the rapidly rising cost of
health care in the U.S. The pace of change is
likely to accelerate as the Clinton Administration brings
forth its solution — managed competition. Under
managed competition, employees will have a choice
among private health plans offering (more or less) standardized benefit packages. Employees will make the
choice on the basis of price and quality, with any cost
above that of the least expensive plan being paid by the
employee rather than the employer. Quality information will presumably include patient satisfaction and
health outcomes data developed by the HIPC (health
insurance purchasing cooperative) that will manage the
system in each area. The Clinton plan is expected also
to provide for coverage of all Americans, including a
requirement that an employer provide coverage for all
employees and dependents regardless of company size.
Most likely, under managed competition, HMOs
will come to cover a majority of the non-elderly population, as compared to the current 15 percent. Experience with federal employees under arrangements
similar to managed competition points to this prediction. The Clinton plan is expected also to include some
form of global budget ceilings, which will create further
pressure to contain increases in health-care spending.
Moreover, even if no major legislation is enacted soon,
employees will continue to seek nontraditional forms
of managed care in an attempt to hold down their
health-care costs. In short, we [radiologists] must
expect that more and more of our work will take place
under payment systems that are decidedly different
from the indemnity fee-for-service system we have
become accustomed to. Indeed, Clinton advisors
expect that even managed conventional care (for example, self-insured large corporations) will become a vanishing arrangement, with PPOs and HMOs covering all
but a small percentage of nonelderly patients. Currently, it appears that Medicare will remain in place as
a health-care system for the elderly, but there will be
increasingly stringent cost controls.
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Implications for Radiologists
The implications of these changes should generally
be favorable to radiology by radiologists. As a
profession we have emphasized good quality at
moderate cost and the elimination of waste, as in selfreferral. However, there will be serious problems as
philosophy becomes reality. For example, cost will
probably be emphasized over quality because cost is
easier to measure; pressures on costs will be continuous even after major savings have been achieved; and it
is easy to predict there will be more competition among
radiology groups.
More specifically, the implications of payment system changes for radiologists will be the consequences
of what happens with payers. Our predictions:
Ronald G. Evens, M.D.
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■ Rapidly dwindling numbers of insurers who pay
billed charges.

■ Given the cost pressures that are likely in all settings, practice efficiency has to be high.

■ Growth of PPOs and HMOs.

■ Capitation contracts or other departures from feefor-service are likely to make the increasing volume
of imaging performed by radiologists (previously
considered a major plus for our profession) into
something of a problem. Under capitation, more
volume means radiologists do more work and have
more practice costs for the same revenue. To
address this problem, the College [ACR] is developing patient-care guidelines — a set of algorithms identifying the appropriate and economical
diagnostic imaging procedures to be used for a
patient, given the patient's presenting condition.
These guidelines will enable radiologists to consult
with referring physicians and point out what studies are appropriate rather than largely following
orders for specific studies. Development of a set of
guidelines can do much to strengthen the argument
for radiology by radiologists and the argument that
radiologists rather than primary-care gatekeepers
should decide on what imaging studies are performed. Such guidelines will be selling points to be
used in negotiations with individual HMOs and
PPOs. However, using the guidelines effectively
will require radiologists to interact in a more active
way with referring physicians.

■Increasing pressure on prices by PPOs, i.e.,
demands for greater discounts.
■ In order for PPOs to remain competitive, they will
develop a greater ability to steer patients away
from practices and hospitals that don't agree to
their terms, e.g., requiring patients to pay 40 percent or more of charges of non-network providers.
■All payers will increasingly use data bases to identify practice patterns in order to profile physicians
and to institute practice guidelines.
■ HMOs will change to meet the organizational
demands of rapid growth, e.g.,
■A desire to contract with one entity, typically a
large multi-specialty group or a large primary care
practice, for all physicians' services in a geographic area. Where the contract is with a primary care practice, that practice will turn around
and subcontract specialty care, including radiology (preferably with a single low bidder).
■Increasing insistence on capitation (rather
than modified fee-for-service) as the method of
contracting.
■ Increasing insistence that the HMO physicians
practice in the hospitals the HMO has selected
and on the HMO's terms.

How Radiologists Can Respond
As with previous changes in our profession, we
should respond in a way that is helpful to our
patients as well as to radiologists. An effective
response should involve actions on several fronts and
should include activity by individual radiology practices
as well as by the ACR [American College of Radiology]
and state radiologic societies. Fundamental issues we
must jointly address:
■ Self-referral generates excessive utilization and
costs as well as undercutting radiologists. It is time
to take action not only on joint ventures (physicians referring to outside facilities in which they
have a financial interest) but also on nonradiologists performing radiologic studies.
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Negotiating managed-care contracts is a complex
and difficult activity. Advice to bear in mind:
■ Contracting is time-consuming and, with the healthcare sysytem changing, contracting is constantly
changing. Don't short-change the time and effort
required to negotiate and to manage large contracts
since these can affect major parts of a practice.
■At least at the start, stay with short-term agreements as a trial of the population. It is hard to predict how much care a population will require. It
varies from one group to another, and the managed-care entity may not have good data initially. If
possible, write stop-loss agreements into the contract so that if actual utilization differs from
expected by more than a certain amount (say 10
percent), payments are adjusted. Also, it will be
necessary to count utilization by RVUs [relativevalue unit] and separately by different types of procedures, so a chest X ray and a CT study will not
count as the same in any analysis.
■ Keep good data on the utilization actually encountered. In particular, maintain accurate records of
the data as this will be the basis for developing
internal financial statistics for use in negotiating.
MALLINCKRODT INSTITUTE OF RADIOLOGY
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■ Be responsive to the demands of managed-care
organizations in proportion to the extent they can
actually deliver (or move away) patients. As noted,
most PPOs currently have relatively limited ability
to move patients.
■ Aim for diversification. Becoming heavily dependent on one managed-care organization makes a
practice more susceptible to pressure from it.
Larger radiology groups or cooperation with other
groups will be essential to meet the needs of managed-care organizations. In larger urban areas,
managed-care organizations will typically want to offer
services at more than one hospital and at several ambulatory sites, but they (or their principal physician
group) will increasingly want to contract with only one
radiology entity. The challenges will be particularly
intense for solo or small-group practices located in relatively large population centers. We predict that the
practice of medicine will undergo consolidation as has
occurred recently in the airline industry.
Cooperative working arrangements with the affiliated hospital will become more important. Hospitals
will be seeking managed-care contracts energetically
and will be in no mood to have features of their exclusive contracts with hospital-based physicians become
significant barriers to obtaining these contracts. Joint
physician-hospital organizations (PHOs), built around a
hospital's medical staff, may become a form of managed-care organization that offers physicians and hospitals a greater role and more rewards than do traditional
managed-care organizations. Support of and involvement in PHOs will be a promising avenue for radiologists and other physicians. However, there are three
cautions:
■ Putting together a successful managed-care
organization requires a good deal of skill and
investment.
■ If the hospital and physician partners insist on all
the rewards of fee-for-service, the PHO will not
succeed in a cost-competitive environment.
■ Beware of the hospital-dominated PHO. Physicians should have a strong role in the governance
of PHOs.

Jonathan H. Sunshine, Ph.D.

But beware! Aggressive provider groups will be looking for high-cost geographic locales as green pastures.
And managed-care organizations may import physicians to an area if they cannot work out satisfactory
arrangements with local physicians.
Overall, we clearly face a period of major changes
and pressures in health-care financing arrangements
over the next few years. At this time, there are no
quick, easy answers for radiologists, and the promised
federal comprehensive reform plan will only make the
situation more fluid — at least, temporarily.
Ronald G. Evens, M.D., director of Mallinckrodt
Institute of Radiology, is secretary-treasurer and the
elected vice-chairman of the ACR Board of Chancellors. Jonathan H. Sunshine, Ph.D., is director of
research for the ACR. This article is an edited version of a newsletter Drs. Evens and Sunshine published for ACR members. A revised version will be
published in an upcoming volume of the American
Journal of Radiology.

The speed and extent of changes will depend on
local conditions. For example, if there is only one radiology group in an area and only one hospital in that
area, competitive pressures will be much less than
where radiology groups and hospitals are numerous.
FOCAL SPOT, SPRING, 1994
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THE DIRECTOR'S
OFFICE REPORT
NEW STAFF
Harold F. Bennett, M.D.,
Ph.D., assistant professor of
radiology, Division of Diagnostic Radiology.
Kim A. Deal, Ph.D.,
research associate, Division
of Radiation Sciences.
Jeffrey A. Dobkin, M.D.,
assistant professor of radiology, Division of Nuclear
Medicine.
Shantanu V. Kaushikkar,
M.S., research associate,
Division of Radiology
Research.
Steven E. Petersen, Ph.D.,
associate professor of radiology, Division of Radiation
Sciences.
Yuming Yin, M.D., research
assistant in radiology, Division of Diagnostic Radiology.
Yimin Zhu, D.Sc, research
associate, Radiation Oncology Center.
Darryl A. Zuckerman,
M.D., assistant professor of
radiology, Division of Diagnostic Radiology.

PROMOTIONS
Ming-shun Chen, Ph.D.,
was promoted to instructor
in radiology, Radiation
Oncology Center.
Ge Wang, Ph.D., was promoted to assistant professor
of radiology, Division of
Radiology Research.

PROMOTIONS
& CHANGE IN
STATUS
Keith C. Fischer, M.D.,
was promoted to associate
professor of radiology, Division of Nuclear Medicine,
and appointed as a full-time
staff member.
Lawrence M. Kotner, Jr.,
M.D., was promoted to associate professor of radiology,
Division of Diagnostic Radiology, and appointed as a
full-time staff member.

Scott A. Mirowitz, M.D.,
was promoted to associate
professor of radiology,
named chief of radiology,
Jewish Hospital, Division of
Diagnostic Radiology, and
appointed as a full-time staff
member.
William R. Reinus, M.D.,
was promoted to associate
professor of radiology, Division of Diagnostic Radiology, and appointed as a
full-time staff member.
Joseph L. Roti Roti, Ph.D.,
was named to a joint appointment as professor of cell
biology and physiology and
as professor of biochemistry
and molecular biophysics.

Paul W. K. Luk, M.S.,
research instructor, Division I
of Nuclear Medicine, completed a one-year appointment and has returned to
Siemens/CTI in Knoxville,
Tennessee.
Vivek Mishra, Ph.D.,
research associate, Radiation Oncology Center, has
accepted a position at
Thomas Jefferson University, Philadelphia.

VISITING PROFESSORS
& INVITED LECTURERS
Dennis M. Balfe, M.D.,
professor of radiology, presented "CT Evaluation of
Hepatic Lesions: Dynamic
Spiral Scans, CT Arterioportography - How to Get the
Most Out of Your CT
Request" at the Refresher
Course and Update in Gastrointestinal Surgery, Washington University School of
Medicine, St. Louis, March
10 and 11.
James A. Brink, M.D.,
assistant professor of radiology, spoke on "Spiral Computed Body Tomography:
Applications in the Chest
and Abdomen" at the CityWide Radiology Conference,
St. Louis, December 13. He
lectured on "Spiral CT" at
the Greater St. Louis Society
of Radiologists' meeting, St.
Louis, January 18. Brink
spoke on "CT Angiography"
at the New York Roentgen
Society meeting, New York,
January 24. As visiting pro-
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OFF STAFF
Venkata R. Devineni,
M.D., associate professor of I
radiology, Radiation Oncology Center, has accepted the I
position of chief of radiation I
oncology, DePaul Health
Center, St. Louis.

fessor, Brink presented "Spiral CT of the Chest and
Abdomen" at New York University, New York, January
25. He lectured on "Radiologic Imaging in Diagnosis
and Management of Acute
Pancreatitis" at the
Refresher Course and
Update in Gastrointestinal
Surgery, Washington University School of Medicine, St.
Louis, March 10 and 11.
Brink participated in the
Cross Sectional Angiography
Workshop at the Society of
Cardiovascular and Interventional Radiology meeting,
San Diego, March 20. He
presented "Spiral CT
Overview" at the Orange
County Radiological Society's meeting, Orange
County, California, March
22. As visiting professor,
Brink spoke on "CT of the
Peritoneal Ligaments" at the
University of California at
Irvine, March 22.
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Patrick D. Datoc, M.D.,
instructor in radiology and a
fellow in magnetic resonance imaging, spoke on "3D
Fat-Suppressed Breathhold
Imaging of the Kidneys" at
the Society of Magnetic Resonance Imaging, Dallas,
\ March 8.
I
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Bahman Emami, M.D.,
FACR, professor of radiology and associate director
for research, Radiation
Oncology Center, as invited
speaker, presented "Head
and Neck Cancer. The
Mallinckrodt Experience:
3D CRT for Head and Neck
Cancers" at the The TwentyNinth Annual San Francisco
Cancer Symposium, Washington, D.C., February 26
and 27.
E. Mark Haacke, Ph.D.,
professor of radiology,
spoke on "Applications of
Contrast Agents to MRA and
Cardiovascular Imaging" at
Mallinckrodt Medical, Imaging Division, St. Louis,
December 7. He presented
"Recent Advances in MRA
and Cardiovascular Imaging"
at the University of Illinois,
Urbana-Champaign, December 8. Haacke also spoke on
"Image Reconstruction and
Post Processing Problems in
MRI" at the University of
Erlangen, Germany, December 13.

, Jay P. Heiken, M.D., professor of radiology and
(cochief of body computed
tomography, as moderator,
■ | presided over the plenary
session on "MRI of the
I Abdomen and Pelvis" at the
j j 12th Annual Meeting of the
Society for Magnetic Reso) nance Imaging, Dallas,
March 7.
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Myles B. Koby, M.D.,
instructor in radiology and a
fellow in neuroradiology,
presented "Cerebral Palsy:
MRI Changes with Clinical
Correlation in 236 Patients"
at the Section on Pediatric
Neurological Surgery, 22nd
Annual Meeting of the American Association of Neurological Surgeons, San
Antonio, December 10.
Benjamin C. P. Lee, M.D.,
associate professor of radiology, presented "MRI Features of Spastic Diplegia and
Quadriplegia at the Current
Concepts of Cerebral Palsy
Following Premature Birth
Seminar, St. Louis, November 19 and 20.
Henry K. Lee, M.D.,
instructor in radiology,
spoke on "Chemoradiation
for Gastrointestinal Tumors"
at the Refresher Course and
Update in Gastrointestinal
Surgery, Washington University School of Medicine, St.
Louis, March 10 and 11.
Bruce L. McClennan,
M.D., professor of radiology
and chief of abdominal imaging, lectured on "Staging
Renal Cell Cancers — Imaging Requirements" at Urology Grand Rounds,
Washington University
School of Medicine, St.
Louis, February 5. He spoke
on "Problem Cases in Renal
CT" at the Sun Valley Imaging Symposium, Sun Valley,
Idaho, March 3 and 4.
McClennan presented "Contrast Media Reaction Update
1994," "Imaging the
Retroperitoneum - Idiopathic
Retroperitoneal Fibrosis and
Lymphadenopathy," and
"Staging Renal Cell Carcinoma — Imaging Armamentarium 1994" at the
University of California,
Diagnostic Course, San Francisco, March 22.

Ali S. Meigooni, Ph.D.,
assistant professor of radiology, as visiting professor,
presented "Nuclear Data
Base Development for Medical Physics Application,"
Lawrence Livermore
National Laboratory, Livermore, California, January 19
- 28. While there, Meigooni
collaborated with the Laboratory's Nuclear Data Group,
in conjunction with the Medical Applications Program in
Livermore, to develop a
Monte Carlo code for simulating dose deposition in
radiation oncology. He
spoke on "Clinical Applications of Radiochromic
Films" at the Greater St.
Louis Chapter of the Health
Physics Society meeting, St.
Louis, February 3.
Stephen M. Moerlein,
Ph.D., associate professor of
radiology, presented two
posters, "Compounding of
[0-15]butanol for PET Blood
Flow Measurements" (coauthored with Gregory G.
Gaehle, B.S., scientific
coordinator; Keith R. Lechner, B.S., senior medical
research technician; and
Michael J. Welch, Ph.D.,
professor of radiology and
director of the Division of
Radiation Sciences) and
"Robotic Preparation of [1n
C]acetate for PET Study of
Diseased Myocardium"
(coauthored with Gaehle;
Lechner; Charles S.
Yahng, B.S., lab assistant;
and Welch) at the 141st
Annual Meeting of the American Pharmaceutical Association, Seattle, March 19 - 23.

Eduardo G. Moros, Ph.D.,
assistant professor of radiology and chief of hyperthermia physics service,
presented "Finite Difference
Model for 3-D Cancer Therapy with Hyperthermia"
(coauthored with William L.
Straube, M.S., instructor in
radiology, and Robert J.
Myerson, M.D., Ph.D.,
associate professor of radiology) at the 114th Winter
Annual Meeting of the American Society of Mechanical
Engineers, New Orleans,
November 28 - December 3.
Carlos A. Perez, M.D., professor of radiology and
director of the Radiation
Oncology Center, spoke on
"High Dose Rate Brachytherapy for Gynecological Cancers" and "The Present
Status of Radiation Therapy
in the Treatment of Cancer"
at the 11th Asia Pacific Cancer Conference, Bangkok,
November 16 -19. He presented "Radiation Therapy
for Carcinoma of the Uterine
Cervix" and "Radiation Therapy for Carcinoma of the
Endometrium" at Chiang Mai
University, Chiang Mai, Thailand, November 20 - 23.

23

FYI
VISITING PROFESSORS
& INVITED LECTURERS
continued from page 23
James A. Purdy, Ph.D.,
professor of radiology and
associate director of the
Radiation Oncology Center,
as keynote speaker, presented "3-D Treatment Planning - A New Era in
Radiotherapy" and lectured
on "Volume and Dose Specifications for 3-D CRT" and
"Multi-Institutional Trials 3D CRT Quality Assurance"
at The Twenty-Ninth Annual
San Francisco Cancer Symposium, Washington, D.C.,
February 26 and 27. He
spoke on "3-D Conformal
Radiation Therapy:
Overview of the Washington
University Experience" at
the XIth International Conference for Computers in
Radiation Therapy, Manchester, England, March 18 - 24.
Henry D. Royal, M.D., professor of radiology and associate director of the Division
of Nuclear Medicine, as
invited speaker, presented
"Pulmonary Embolism: Scientific Challenges" at The
Eighth Annual Daniel R.
Biello Memorial Lecture. St.
Louis, February 14. He
spoke on "Health Effects of
Radiation" and "Health
Effects of the Chernobyl
Accident" at the Bethesda
Naval Medical Center, Maryland, March 7. As invited
lecturer for the 10th H.
Leonard Warres Lecture,
Royal spoke on "Technology
Assessment and Health Care
Reform: Scientific Challenges," University of Maryland Medical System,
Baltimore, March 17.
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Gregory R. Saboeiro,
M.D., instructor in radiology
and a fellow in vascular and
interventional radiology,
spoke on "Percutaneous
Cholecystostomy: Experience in 200 Patients" at the
Society of Cardiovascular
and Interventional Radiology
meeting, San Diego, March
23.
Stuart S. Sagel, M.D., professor of radiology, chief of
chest radiology, and cochief
of body computed tomography, lectured on "Chest Radiography: Low Technology to
High Technology" and "Spiral CT in the Evaluation of
Thoracic Vascular Disease"
at the 60th Anniversary Symposium of the Hellenic Radiologic Society, Athens,
Greece, December 11 and 12.
As visiting professor, he presented "Spiral CT in the Thorax," "CT of Non Vascular
Mediastinal Masses," and
"CT of Focal Pulmonary
Lesions" to the Department
of Radiology, Bowman Gray
School of Medicine, Winston-Salem, January 20 and
21. As guest lecturer, Sagel
spoke on "CT of Vascular
Mediastinal Lesions" at the
New England Roentgen Ray
Society, Boston, March 18.

Janice W. Semenkovich,
M.D., instructor in radiology,
presented "Ventilation - Perfusion Imaging: Utility in
Diagnosis of Non-thrombotic
Disease," at the Society of
Thoracic Imaging, Scottsdale, Arizona, March 11.

O. Clark West, M.D.,
instructor in radiology, presented "Trauma Radiography" at the 4th District of the
Missouri Society of Radiologic Technologists Educational Seminar, St. Louis,
February 5.

Joseph R. Simpson, M.D.,
Ph.D., FACR, associate professor of radiology, presented "Salvage Treatment
for Early Glottic Failure" and
"Radiotherapeutic Management of Pyrif orm Sinus
Malignancy" at the Second
World Congress of Laryngeal
Cancer, Sydney, Australia,
February 20 - 24.

Anthony J. Wilson, M.B.,
Ch.B., associate professor of
radiology and director of
emergency radiology, gave a I
case presentation and spoke I
on "Ankle Fractures" at Har- I
borview Hospital, University I
of Washington, Seattle, Feb- I
ruary 11. He presented 10
lectures on "Musculoskeletal |
Magnetic Resonance Imaging" at the International
Diagnostic Radiology
Course, Davos, Switzerland,
March 19 - 25.

Michael J. Welch, Ph.D.,
professor of radiology and
chemistry and director of the
Division of Radiation Sciences, as guest speaker, presented "Cyclotron and PET
for Developing Countries" at
the 25th Annual Conference
of the Society of Nuclear
Medicine (India) and Annual
Symposium by The IndoAmerican Society of Nuclear
Medicine, New Delhi,
December 14-17.

Franz J. Wippold, M.D.,
associate professor of radiology, lectured on "Role of
MRI in Head and Neck Imag- I
ing," "Imaging the Temporal
Bone," "Cystic Lesions of the |
Neck," "Cervical Lymphadenopathy," and "The
Larynx" at the Head and
Neck Symposium, Hollywood, Florida, February 4
and 5.
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SYMPOSIA
AMERICAN
SOCIETY FOR
THERAPEUTIC
RADIOLOGY AND
ONCOLOGY
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The following Mallinckrodt
Institute staff members
(highlighted in boldface
type) participated in the
35th Annual Scientific
Meeting of the American
Society for Therapeutic
Radiology and Oncology
(ASTRO), New Orleans,
October 11 -15.
Perry W. Grigsby, M.D.,
chairman, Long Range Planning Committee; member,
Abstract Revew Committee.
Todd H. Wasserman, M.D.,
member, Long Range Planning Committee.

SCIENTIFIC
SESSIONS
Perry W. Grigsby, M.D.,
comoderator, Scientific Session A, "Gynecology -1."
Todd H. Wasserman, M.D.,
comoderator, Scientific Session T, "Chemical Modifiers."
Walter R. Bosch, D.Sc;
Daniel A. Low, Ph.D.; Russell L. Gerber, M.S.; Jeff
M. Michalski, M.D.; Mary
V. Graham, M.D.; Carlos
A. Perez, M.D.; William B.
Harms, B.S.; James A.
Purdy, Ph.D., "An Electronic Viewbox Tool for
Radiation Therapy Treatment Verification."
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Bahman Emami, M.D.,
"Phase III Study of Interstitial Thermoradiotherapy
Compared with Interstitial
Radiotherapy Alone in the
Treatment of Recurrent or
Persistent Human Tumors:
A Prospectively Controlled
Randomized Study by the
Radiation Therapy Oncology
Group."

James V. Piephoff, M.D.;
Jeff M. Michalski, M.D.;
Walter R. Bosch, D.Sc;
Mary V. Graham, M.D.;
William B. Harms, B.S.;
James A. Purdy, Ph.D.;
Carlos A. Perez, M.D., "A
Method to Evaluate the
Impact of Daily Treatment
Variation on 3-Dimensional
Dose Distribution."

Mary V. Graham, M.D.;
Nilesh L. Jain, M.S.*; Michael
G. Kahn, M.D.*; Robert E.
Drzymala, Ph.D.; Michael
A. Mackey, Ph.D.; James
A. Purdy, Ph.D., "Validation
and Clinical Usefulness of an
Objective Plan Evaluation
Model in the Three-Dimensional Treatment of NonSmall Cell Lung Cancer."
*Division of Medical Informatics, Department Of Internal Medicine and Department of Computer Science,
Washington University
School of Medicine, St.
Louis.

Richard Valicenti, M.D.;
Jeff M. Michalski, M.D.;
Russell L. Gerber, M.S.;
Mary V. Graham, M.D.;
Abel Y. Cheng, M.S.; Walter R. Bosch, D.Sc; James
A. Purdy, Ph.D.; Carlos A.
Perez, M.D., "Comparison
of Weekly Port Films and
On-Line Portal Images in
Estimating Treatment
Variation."

Ryuji Higashikubo, Ph.D.;
Robert S. Malyapa, M.D.,
Ph.D.; Joseph L. Roti Roti,
Ph.D., "Flow Cytometric
Studies of SI Nuclease
Digestion Kinetics and Its
Application in the Determination of Intrinsic Cellular
Radiation Sensitivity."
Carlos A. Perez, M.D.;
Mary V. Graham, M.D.;
Bahman Emami, M.D.;
Russell L. Gerber, M.S.;
John W. Matthews, D.Sc;
William B. Harms, B.S.;
James A. Purdy, Ph.D., "A
Fully Integrated CT-Simulator: Conceptual Design and
Clinical Applications."

PANEL DISCUSSIONS
Todd H. Wasserman, M.D.,
moderator, "Quality of Life:
A New Endpoint in Outcome
Analysis."
POSTER
PRESENTATIONS
Perry W. Grigsby, M.D.;
Jonathan A. Haas, B.A.*;
Barry A. Siegel, M.D.,
"Utility of Pre- and PostTreatment Total Body 1-131
Scans in Patients with Thyroid Carcinoma." *medical
student, Washington University School of Medicine, St.
Louis.

Robert J. Myerson, M.D.,
Ph.D.,; Jeff M. Michalski,
M.D.; Maurice L. King,
M.D.; Elisa Birnbaum, M.D.*;
James Fleshman, M.D.*;
Robert Fry, M.D.*; Ira J. Kodner, M.D.*; David Lacey,
M.D.**; Mary Ann Lockett,
MBA, "Adjuvant Radiation
Therapy for Rectal Carcinoma: Predictors of Outcome." *Department of
Surgery, Washington University School of Medicine, St.
Louis. **Department of
Pathology, Washington University School of Medicine,
St. Louis.
Marie E. Taylor, M.D.;
Carlos A. Perez, M.D.;
Karen J. Halverson, M.D.*;
Robert R. Kuske, M.D.**;
Robert J. Myerson, M.D.,
Ph.D.; Joseph R. Simpson,
M.D., Ph.D., "Factors
Affecting Cosmesis After
Breast Conservation Ther*Department of Radiation Oncology, St. Luke's
Hospital, St. Louis.
**Department of Radiation
Oncology, Ochsner Clinic,
New Orleans.

REFRESHER
COURSES
Perry W. Grigsby, M.D.,
"Carcinoma of the
Endometrium - Prognostic
Factors and Management."
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MIDWESTERN
REGIONAL
RADIATION
RESEARCH
The following Mallinckrodt
Institute staff members
(highlighted in boldface
type) participated in the
Ninth Annual Meeting of
Midwestern Regional Radiation Research, St. Louis,
November 12 - 14.
Joseph L. Roti Roti, Ph.D.,
chairperson, Organizing
Committee.
Douglas R. Spitz, Ph.D.;
Joseph L. Roti Roti, Ph.D.,
members, Program
Committee.
Kathy Bles, James Patterson, Naima Sidiqi, members, Local Arrangements
Committee.

SYMPOSIUM

i: FREE

RADICAL BIOLOGY
AND GLUTATHIONE
Michael A. Mackey, Ph.D.,
chairperson.
Douglas R. Spitz, Ph.D.;
John W. Phillips, Ph.D.*;
Donna T. Adams, B.S.**; C.
Michael Sherman,**; Dennis
F. Deen, Ph.D.*; Gloria C. Li,
Ph.D.*, "Cellular Resistance
to Oxidative Stress Is
Accompanied by Resistance
to Cisplatin: The Significance of Increased Catalase
Activity and Total Glutathione in Hydrogen Peroxide-Resistant Fibroblasts."
*University of California, San
Francisco. **University of
Virginia, Charlottesville.
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Douglas R. Spitz, Ph.D.;
Shannon J. Sullivan, M.D.;
Michael T. Kintner, Ph.D.*;
Donna T. Adams, B.S.*; C.
Michael Sherman, B.S.*;
Robert J. Roberts, Ph.D.*,
"Mechanisms of Resistance
to Oxifative Stress 02-Resistant Cells." *University of
Virginia, Charlottesvlle.

SYMPOSIUM IL
HYPERTHERMIA
Ming-shun Chen, Ph.D.;
Albert Fornace, Ph.D.*;
Andrei Laszlo, Ph.D.,
"Analysis of an HSP 70
Related Clone from Chinese
Hamster Cells Suggests that
It Encodes a 33Kd Protein
Related to the 67 Kd Protein
Related to the 67 Kd High
Affinity Laminin." *National
Institutes of Health,
Bethesda.
Nazan Turkel, M.S.;
Joseph L. Roti Roti, Ph.D.,
"The Possibility That Incomplete Removal of HMNP
Could Play a Role in HeatInduced Cellular Lethality."
Robert P. van der Waal,
Ph.D.; K. George Thampy,
Ph.D.; William D. Wright,
B.S.; Joseph L. Roti Roti,
Ph.D., "Heat-Induced Modifications in the Association of
Specific Proteins with the
Nuclear Matrix."
Ming-shun Chen, Ph.D.;
Andrei Laszlo, Ph.D., "Differential Expression of Various HSP 70 Family mRNAs
in Chinese Hamster Cells."
Andrei Laszlo, Ph.D.; Teri
Davidson, M.A.; An Hu,
M.S., "Possible Function of
the Intercellular Localization
of HSC 70 in Mammalian
Cells."

WORKSHOP I: MODES
OF CELL DEATH
Andrei Laszlo, Ph.D.,
chairperson.
Robert S. Malyapa, M.D.,
Ph.D.; Xiafang Zhang,
M.D.; Michael A. Mackey,
Ph.D.; Joseph L. Roti Roti,
Ph.D., "Characterization of
Mode of Cell-Death after
Acute Hyperthermia."
Michael A. Mackey, Ph.D.;
Robert S. Malyapa, M.D.,
Ph.D.; Xiafang Zhang,
M.D., "Mode of Cell Death
during Long Duration Treatment of HeLa Cells at
41.5°C."
Yvonne C. Taylor, Ph.D.;
Azemat J. Parsian, B.S.,
"Is the p53-Related Gl Delay
a Cell Cycle Checkpoint
(promoting cellular recovery) or a Cell Cycle Checkout Point (representing a
terminal phenotype) in Irradiated Human Fibroblasts?"
WORKSHOP II:
CELL CYCLE DEPENDENT GENE EXPRESSION AND TUMOR
SUPPRESSOR GENES
Prabhat C. Goswami,
Ph.D.; Clayton R. Hunt,
Ph.D.; Weihua He, M.S.;
Joseph L. Roti Roti, Ph.D.,
"Accelerated GrTransit Following Transient Inhibition
of DNA Replication-Possible
Role of GrCyclins."
Clayton R. Hunt, Ph.D.;
Prabhat C. Goswami,
Ph.D.; Weihua He, M.S.;
Joseph L. Roti Roti, Ph.D.,
"Cell Cycle Regulated
Expression of Topoisomerase II Is Disrupted by
Heat and Radiation."

Yvonne C. Taylor, Ph.D.;
Azemat J. Parsian, B.S.,
"Alterations in the Nuclear
(Matrix) Association of
Tumor Suppressor Gene
Products in Irradiated
Human Fibroblasts Undergo-1;
ing Gj Arrest."

WORKSHOP IIL
CHROMATIN STRUCTURE, NUCLEAR
MATRIX AND RADIATION REPAIR
Ryuji Higashikubo, Ph.D.; I
Robert S. Malyapa, M.D.,
Ph.D.; Joseph L. Roti Roti, |
Ph.D., "SI Nuclease Digestion Kinetics and Its Applica-1
tion in the Determination of I
Intrinsic Cellular Radiation
Sensitivity."
William D. Wright, B.S.;
Robert S. Malyapa, M.D.,
Ph.D.; Joseph L. Roti Roti, 1
Ph.D., "Nuclear Matrix Protein Content and DNA Loop
Rewinding in Cell Lines of
Varying Radiosensitivity."

RADIOLOGICAL
SOCIETY OF
NORTH AMERICA
The following Mallinckrodt
Institute staff members
(highlighted in boldface
type) participated in the
79th Scientific Assembly
and Annual Meeting of the
Radiological Society of
North America (RSNA),
Chicago, November 28 December 3.

SPECIAL FOCUS
SESSION
R. Gilbert Jost, M.D., presiding, "The All-Digital Radiology Department: Is It Just
Around the Corner?"

MALLINCKRODT INSTITUTE OF RADIOLOGY

IMAGING SYMPOSIUM SPIRAL (HELICAL) CT:
PRINCIPLES, TECHNIQUES, AND CLINICAL APPLICATIONS
James A. Brink, M.D., panel
member, "Principles and Technical Considerations."
Jay P. Heiken, M.D., panel
member, "Abdominal Applications of Spiral CT."
RSNA-AUR-ARRS
INTRODUCTION TO
RESEARCH PROGRAM
Stuart S. Sagel, M.D., "Oral
Presentation of Research."

REFRESHER COURSES
Dennis M. Balfe, M.D.;
William E. Torres, M.D.*,
"Incidental Liver Lesion."
*Emory University, Atlanta,
Ronald G. Evens, M.D.;
Jonathan Sunshine, Ph.D.*,
"Managed Competition: Current Major Proposal from the
Clinton Administration."
*American College of Radiology, Reston, Virginia.
Jay P. Heiken, M.D.; Janet
I E. S. Husband, FRCP, FRCR*,
"CT and MR Imaging of Pelvic
Neoplasms." *Royal Marsden
Hospital, Sutton, England.
Marshall E. Hicks, M.D.;
Michael D. Dake, M.D.*, "Percutaneous Endovascular
Recanalization Techniques
for the Treatment of Chronic
Occlusive Vascular Disease."
*Department of Radiology,
Stanford University.

William H. McAlister,
M.D.; Alan S. Brody, M.D.*,
"Pediatric Imaging:
Paranasal Sinuses and Nasal
Cavities." *Department of
Radiology, Children's Hospital of Buffalo.
Jeff M. Michalski, M.D.;
John W. Wong, Ph.D.*, "RealTime Portal Imaging."
*William Beaumont Hospital,
Royal Oak, Michigan.
William D. Middleton,
M.D., "US of the Male Reproductive System - Testes and
Scrotum."
Barbara S. Monsees, M.D.;
Judy M. Destouet, M.D.*,
"Practical Aspects of Performing Screening Mammography." *Private practice,
Baltimore.
Barbara S. Monsees, M.D.,
panel member, "Imaging of
the Surgically Altered
Breast."
Robert J. Myerson, M.D.,
Ph.D.; Leonid B. Leybovich,
Ph.D.*, "Improved Methods
of Hyperthermia Delivery."
*Loyola Medical Center,
Naperville.
Daniel Picus, M.D.; Timothy C. McCowan, M.D.*;
Michael J. Pentecost, M.D.**,
"Venous Thromboembolic
Disease: Fibrinolytic Therapy and Inferior Vena Cava
Filters." *Department of
Radiology, University of
Nebraska, Omaha. **Department of Radiology, University of Pennsylvania,
Philadelphia.
Henry D. Royal, M.D.,
"Effects of Low-Level Radiation: Scientific, Political,
and Social Views."
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Stuart S. Sagel, M.D.;
Elliot K. Fishman, M.D.*;
Patrick F. Sheedy, M.D.**,
"Fast CT Scanning: Clinical
Applications of Spiral and
Electro-Beam CT." *Department of Radiology, Johns
Hopkins Hospital, Baltimore.
**Department of Diagnostic
Radiology, Mayo Clinic,
Rochester.
Marilyn J. Siegel, M.D.;
George S. Bisset, M.D*,
"Pediatric Body CT and MR:
Problem Areas and Pitfalls."
*Children's Hospital Medical
Center, Cincinnati.

CATEGORICAL
COURSES
Louis A. Gilula, M.D.,
comoderator, "Categorical
Course in Musculoskeletal
Radiology Advanced Imaging
of Joints: Theory and Practice - General Principles,"
"Categorical Course in Musculoskeletal Radiology
Advanced Imaging of Joints:
Theory and Practice - The
Wrist, Specialized Plain
Films and CT Scanning:
Techniques, Indications, and
Findings," "Categorical
Course in Musculoskeletal
Radiology Advanced Imaging
of Joints: Theory and Practice - The Elbow and Shoulder," "Categorical Course in
Musculoskeletal Radiology
Advanced Imaging of Joints:
Theory and Practice - The
Hip," "Categorical Course in
Musculoskeletal Radiology
Advanced Imaging of Joints:
Theory and Practice - The
Knee," and "Categorical
Course in Musculoskeletal
Radiology Advanced Imaging
of Joints: Theory and Practice - The Foot and Ankle."

WORKSHOPS
WiUiam D. Middleton,
M.D.; Mitzi Fields, RDMS.*;
Kevin P. Lee, CRT, RDMS**;
Philip W. Rails, M.D.**;
Ronald R. Townsend,
M.D.***; Laurence A. Mack,
M.D.****; Edward G. Grant,
M.D.**, "Practical Abdominal
Color Doppler ("Hands-on"
Workshop)." *University of
Alabama, Birmingham.
**University of Southern California - Los Angeles Campus
Medical Center. ***Division
of Body Imaging, University
of Colorado Health Sceinces
Center, Denver. ****Department of Radiology, University of Washington School of
Medicine, Seattle.
SCIENTIFIC
SESSIONS
Michael D. Darcy, M.D.,
presiding, Scientific Sessions
- Cardiovascular.
Harvey S. Glazer, M.D.,
program committee member,
Chest Radiology.
Jay P. Heiken, M.D., presiding, Scientific Sessions General (CT).
Bruce L. McClennan,
M.D., chairman, program
committee, Genitourinary
Radiology.
Barry A. Siegel, M.D., presiding, Scientific Sessions Nuclear Medicine (PET,
Oncology).
Todd H. Wasserman, M.D.,
program committee member,
Radiation Oncology/
Radiobiology.
Anthony J. Wilson, M.B.,
Ch.B, presiding, Scientific
Sessions - Bone (MR Imaging
and Spectroscopy).
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D. Claire Anderson, M.D.;
Harvey S. Glazer, M.D.;
Janice W. Semenkovich,
M.D.; Joel D. Cooper, M.D.*:
R. Sudhir Sundaresan, M.D.*;
G. Alec Patterson, M.D.*,
"Chest Radiography after
Lung Transplantation: First
10 Days." *Department of
Surgery, Washington University School of Medicine, St.
Louis.
James A. Brink, M.D.;
Lane A. Deyoe, M.D.; Jay
P. Heiken, M.D.; Ge Wang,
Ph.D.; Roberta L. Yoffie,
R.T.; Michael W. Vannier,
M.D., "Spiral CT Angiography for Renal Arterial Stenosis: In Vitro Assessment of
Technical Parameters."
Clifford K.S. Chao, M.D.;
Mary V. Graham, M.D.;
Daniel A. Low, Ph.D.;
Todd H. Wasserman, M.D.,
"Three-dimensional CTderived Model for Estimating
Lung Volume Irradiated from
Simulation Films."
Thomas E. Conturo, M.D.,
Ph.D.; John D. Strandberg,
Ph.D., D.V.M.*; Brian J.
Soher, B.E.E.*; Peter B.
Barker, D. Phil*; James H.
Anderson, Ph.D.*, "Assessment of Tumor Perfusion
and Blood-Brain-Barrier
Leakage with Phaseenhancement Effects of Contrast Agents." *Johns
Hopkins Hospital, Baltimore.

Michael D. Darcy, M.D.;
Daniel Picus, M.D.;
Thomas M. Vesely, M.D.;
Marshall E. Hicks, M.D.;
Leanna Dick, M.D.*; Mark
Mayhle, M.D.**; et al, "Efficacy and Complications of
Transjugular Intrahepatic
Portosystemic Shunts."
*Durham Radiology Associates, Durham, North Carolina. **Rock Hill Radiologists, Raytown, Missouri.
Michael D. Darcy, M.D.;
Darryl Zuckerman, M.D.*;
Daniel Picus, M.D.;
Thomas M. Vesely, M.D.;
Marshall E. Hicks, M.D.;
Thomas Bocchini, M.D.*,
"Evaluation of Risk Factors
for Development of
Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt
Placement." *Saint Louis
University, St. Louis.
Gopal R. Desai, M.D.;
Ryuji Higashikubo, Ph.D.;
David L. Lacey, M.D.*;
Manuel Ribero, M.D.**;
Robert J. Myerson, M.D.,
Ph.D.; Ira J. Kodner,
M.D.***; et al, "Predictive
Assays in the Therapy of
Carcinoma of the Rectum
Treated with Preoperative
Radiation and Correlation
with Clinical Outcome."
*Department of Pathology,
Washington University
School of Medicine, St.
Louis. **Department of
Surgery, Rua Augusto Lessa,
Portugal. ***Department of
Surgery, Washington University School of Medicine, St.
Louis.
Richard N. Edelstein,
M.D.; Shawn P. Quillin,
M.D.; Bruce L. McClennan,
M.D., "Urethrographic Evaluation after Penile Gunshot
Wounds."
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Howard P. Forman, M.D.;
James A. Brink, M.D.;
Dennis M. Balfe, M.D.;
Frank J. Schlueter, M.D.;
Jay P. Heiken, M.D., "Positive-contrast Spiral CT
Cholangiography Following
Oral Administration of Calcium Ipodate: Feasibility
Study."

Jay P. Heiken, M.D.; James
A. Brink, M.D.; Bruce L.
McClennan, M.D.; Stuart
S. Sagel, M.D.; Tamara M.
Crowe, R.T.; Mary Virginia i
Gaines, B.S., "Dynamic Contrast-enhanced CT of the
Liver: Comparison of Volumes and Concentrations of
Contrast Media."

Lee A. Fox, B.S.*; Michael
W. Vannier, M.D.; O. Clark
West, M.D.; Anthony J.
Wilson, M.B., Ch.B; Gregg
A. Baran, M.D.**; Thomas
K. Pilgram, Ph.D., "Imaging
of Midfacial Fractures: Comparative Study of Spiral CT,
3D Reconstructions, and
Multiplanar Reformations."
*medical student, Washington University School of
Medicine, St. Louis. **Private practice, St. Petersburg,
Florida.

Daniel Keleti, M.D.;
V. Rao Devineni, M.D.*,
"Esoph-ageal Stricture: Surveillance of 20 Cases and a
Review of the Literature."
*Department of Radiation
Oncology, DePaul Health
Center, St. Louis.

Harvey S. Glazer, M.D.;
Janice W. Semenkovich,
M.D.; D. Claire Anderson,
M.D.; Elbert P. Trulock,
M.D.*; G. Alec Patterson,
M.D.**; Joel D. Cooper,
M.D.**, "Complications in
the Native Lung Following
Single-Lung Transplantation." *Department of Internal Medicine, Washington
University School of Medicine, St. Louis. **Department of Surgery, Washington
University School of Medicine, St. Louis.
Carolyn A. Haerr, M.D.;
Louis A. Gilula, M.D.;
Frederick A. Mann, M.D.*;
Yuming Yin, M.D.; Claus F.
Larsen, M.D., Ph.D.**, "Accurate Assessment of the
"True" Neutral Posteroanterior and Lateral Projections
of the Wrist: Importance of
Determining Ulnar Variance." *Department of Radiology, Harborview Hospital,
University of Washington
Medical Center, Seattle. **
Odense University Hospital,
Odense, Denmark.

Benjamin C. P. Lee, M.D.;
T. S. Park, M.D.*; Bruce A.
Kaufman, M.D.*, "SingleVoxel Proton Spectroscopy
of Pediatric Brain Tumors."
*Department of Neurological
Surgery, Washington University School of Medicine,
St. Louis.
Henry K. Lee, M.D.;
Ganesh Ramachandran,
B.S.; Perry W. Grigsby,
M.D.; Ernesto Molmenti,
M.D.; Allison Buckner,
B.S.; Rahman Emami, M.D.,
"Prognostic Factors for Papillary and Follicular Thyroid
Carcinoma: Findings at
Long-term Follow-up."
Debiao Li, Ph.D.; E. Mark
Haacke, Ph.D.; Tasneem N.
Khimji, M.D.*; David Miller*,
"MR Angiography of the
Renal Arteries with IR and
Fat Saturation Techniques."
*Case Western Reserve
University, Cleveland.
Gary D. Luker, M.D.; Marilyn J. Siegel, M.D., "Scrotal
and Testicular Enlargement
in Pediatric Patients: Evaluation with Color Doppler US.'
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Charles T. McConnell, Jr.,
M.D.; Mokhtar H. Gado,
M.D.; Benjamin C.P. Lee,
M.D.; Daniel K. Kido,
M.D.; Michael G. Crowley,
Ph.D., "Evaluation of the
Clinical Utility of Fast SE in
Single- and Dual-Contrast
Modes."

Timothy R. O'Leary, M.D.;
Todd H. Wasserman, M.D.;
Nancy A. Kucik, clinical
research associate,
"Treatment of Localized
Supradiaphragmatic Intermediate-Grade Non-Hodgkin
Lymphoma with Radiation
Therapy Alone: Tumor Size
as a Selection Factor."

Charles T. McConnell, Jr.,
M.D.; Joseph F. Plouffe,
M.D.*; Thomas M. File,
M.D.**; Charles F. Mueller,
M.D.*; Barbara J. Marston,
M.D.***; Robert F. Breiman,
M.D.***, "Radiographic Manifestations of Chlamydia
pneumoniae Pneumonia."
*Ohio State University,
Columbus. **Akron City
Hospital, Akron. ***Centers
for Disease Control, Atlanta.

Shawn P. Quillin, M.D.;
Marilyn J. Siegel, M.D.,
"Efficacy of Color Doppler
Sonography for Appendicitis," "Color Doppler US of
Painful Ovary in Adolescents," "Gastrointestinal
Inflammation: Color Doppler
US," and "Posttransplantation Lymphoproliferative Disorders in Children: Intraabdominal Manifestations."

Eric S. Maiden, M.D.;
Daniel Picus, M.D.;
Thomas M. Vesely, M.D.;
Michael D. Darcy, M.D.;
Marshall E. Hicks, M.D.,
"Comparison of Stepping
DSA with Conventional
Screen-Film Angiography for
Evaluation of Peripheral Vascular Disease."
Mary A. Middleton, M.D.;
William D. Middleton,
M.D.; Meaghan M. O'Connor,
M.D.*; David Keetch, M.D.*;
Steve M. Dierks, M.D.*,
"Sonographic Prediction of
Viability in Testicular Torsion." *Division of Urologic
Surgery, Washington University School of Medicine, St.
Louis.
Robert J. Myerson, M.D.,
Ph.D.; Jeff M. Michalski,
M.D.; Maurice L. King,
M.D.; Elisa Birnbaum, M.D.*;
James Fleshman, M.D.*;
Robert Fry, M.D.*; et al,
"Adjuvant Radiation Therapy
for Rectal Carcinoma: Predictors of Outcome."
*Department of Surgery,
Washington University
School of Medicine, St.
Louis.
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Cynthia K. Rigsby, M.D.;
Marilyn J. Siegel, M.D.,
"Patterns of Perirenal Spread
of Wilms Tumor."
Frank J. Schlueter, M.D.;
Ge Wang, Ph.D.; Paul S.
Hsieh, M.D.*; James A.
Brink, M.D.; Michael W.
Vannier, M.D., "Improved
Longitudinal Axis Resolution
in Spiral CT by Means of
Deconvolution Techniques."
*Department of Radiology,
Cedars-Sinai Medical Center,
Los Angeles.
Janice W. Semenkovich,
M.D.; Harvey S. Glazer,
M.D.; D. Claire Anderson,
M.D.; Joseph M. Arcidi,
M.D.*; Frank J. Schlueter,
M.D.; G. Alec Patterson,
M.D.**, "CT Follow-up of
Bronchial Anastomotic Complications after Lung Transplantation." *Cleveland
Clinic Foundation, Cleveland. **Department of
Surgery, Washington University School of Medicine, St.
Louis.

Felix L. Song, M.D.;
William D. Middleton,
M.D.; Thomas C. Winter,
M.D.*; Paul E. Swanson,
M.D.**; Laurence A. Mack,
M.D.*, "Association Between
Intratubular Germ Cell Neoplasia and Testicular
Microlithiasis." *University
of Washington, Seattle.
**Department of Pathology,
Washington University
School of Medicine, St.
Louis.
Kirk E. Smith, AAS; Gulab
H. Bhatia, MSEE; Michael
W. Vannier, M.D., "Assessment of Mass Properties of
the Human Head with Use of
Different 3D Imaging
Modalities."

O. Clark West, M.D.; Stuart
E. Mirvis, M.D.*; Kathirkamanathan Shanmuganathan,
M.D.*, "CT Patterns of
Transsphenoidal Basilar
Skull Fractures." *University
of Maryland Medical System,
Baltimore.
SCIENTIFIC
EXHIBITS
Benjamin C. P. Lee, M.D.;
Edward C. Angtuaco, M.
D.; Robert C. Wood, M.D.;
Daniel K. Kido, M.D.;
Michael G. Crowley,
Ph.D., "Frequency-selective
Fat-Suppression: Principle
and Clinical Applications in
the Spine."

Richard K. Valicenti, M.D.;
Todd H. Wasserman, M.D.;
Nancy A. Kucik, clinical
research associate,
"Whole-Abdomen Irradiation
in Abdominal Non-Hodgkin
Lymphoma Patients."

Kevin W. McEnery, M.D.;
Anthony J. Wilson, M.B.,
Ch.B; William A. Murphy,
Jr., M.D.*, "Comparison of
Standard and Spiral CT in
the Evaluation of Wrist
Trauma." *Division of Diagnostic Imaging, M.D. Anderson Cancer Center, Houston.

Michael W. Vannier, M.D.;
Paul K. Commean, B.S.;
Gulab H. Bhatia, MSEE;
Kirk E. Smith, AAS, "Validation of Spiral CT and Optical Surface Scanning for Use
in 3D Design of Limb
Prosthesis."

Kevin W. McEnery, M.D.;
Anthony J. Wilson, M.B.,
Ch.B; William A. Murphy,
Jr., M.D.*, "Spiral CT Evaluation of Musculoskeletal
Trauma." *Division of Diagnostic Imaging, M.D. Anderson Cancer Center, Houston.

Ge Wang, Ph.D.; Michael
W. Vannier, M.D., "Spiral
CT Image Noise: Analytic
Results."

L. Santiago Medina, M.D.;
Marilyn J. Siegel, M.D.;
Pablo A. Bejarano, M.D.*,
cum laude award for "Imaging and Pathologic Correlation in Pediatric Lung
Transplantation." *Department of Pathology, Washington University School of
Medicine, St. Louis.

Ge Wang, Ph.D.; Michael
W. Vannier, M.D.; Roberta
L. Yoffie, R.T., "StairStep
Artifacts in Spiral CT: A
Phantom Study."

Stuart E. Mirvis, M.D.*;
Kathirkamanathan Shanmuganathan, M.D.*; Charles S.
White, M.D.*; O. Clark
West, M.D.; Michael I. Rothman, M.D.*; Greg H. Zoarski,
M.D.*; "Current Concepts in
Trauma Imaging." ♦University of Maryland Medical System, Baltimore.
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SYMPOSIA
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Allen B. Oser, M.D.; Benjamin C. P. Lee, M.D.;
Daniel K. Kido, M.D.;
Michael G. Crowley, Ph.D.,
"Two-dimensional and 3D
High-Resolution Turbo SE of
the Temporal Bone."
Shawn P. Quillin, M.D.;
Lane A. Deyoe, M.D.;
William D. Middleton,
M.D.; Michael D. Darcy,
M.D.; Sharlene A. Teefey,
M.D.; James A. Brink, M.D.,
"Evaluation of Doppler Criteria Used to Diagnose Transjugular Intrahepatic
Portosystemic Shunt
Complications."
Richard M. Slone, M.D.,
"Reproducing Radiographs
from Slides."
Richard M. Slone, M.D.;
Karl E. Weingarten, M.D.*,
"Skeletal Disease Findings on
Chest Radiographs." University of Florida, Gainesville.
Nhan P. Truong, M.D.*; Wilfred C. Peh, M.D.; William
G. Totty, M.D.; Louis A.
Gilula, M.D., "MR Imaging of
Soft-Tissue Masses around
the Hand and Wrist." *St.
Francis Hospital, Tulsa.
Nhan P. Truong, M.D.*; Frederick A. Mann, M.D.**; Louis
A. Gilula, M.D.; Si-Won
Kang, M.D.***, "Tailored
Wrist Instability Series and Its
Cost-effectiveness." *St.
Francis Hospital, Tulsa.
**Department of Radiology,
Harborview Hospital, University of Washington Medical
Center, Seattle. ^Department of Radiology, Dae-Jeon
St. Mary's Hospital, Catholic
University Medical College,
Dae-Jeon, Korea.
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Nhan P. Truong, M.D.*;
William G. Totty, M.D.;
Louis A. Gilula, M.D., "Tailored Imaging Approach to
Ankle Tendon and Tendon
Sheath Disease." *St. Francis
Hospital, Tulsa.
Yuming Yin, M.D.; Wang
Yun Zhao, M.D.; Anthony
J. Wilson, M.B., Ch.B;
Louis A. Gilula, M.D.,
"Endemic Fluorosis of Bone:
A Disorder with Diverse
Appearance."
INFORAD EXHIBITS
R. Gilbert Jost, M.D., member, Electronic Communications Committee.
Stephen M. Moore, M.S.;
G. James Blaine III, D.Sc;
David E. Beecher, M.S.;
Sheldon Hoffman, M.S.,
"ACR-NEMA/DICOM
Demonstration."
NEMA Seminar
Robert Hindel, Ph.D.,
cochairman*; G. James
Blaine III, D.Sc, cochairman; et al**, "Implementation
of the DICOM 3.0 Standard."
* chairman, National Electrical Manufacturers Association (NEMA) MedPacs;
representative for Philips
Medical Systems; president
of RH Consulting. **other
representatives affiliated
with University of Oldenburg,
Germany; Merge Technologies Inc.; Kodak Health Imaging Systems; Pennsylvania
State University; RSNA
Electronic Communication
Committee.

HONORS/
AAARDS
Clifford K.S. Chao, M.D.,
instructor in radiology,
received the 1993 Resident
Assay Award from the
American Endocuritherapy
Society for his paper,
"Brachytherapy Related
Medical Complication in
Medical Inoperable Stage I
Endometrial Carcinoma."
William H. McAlister,
M.D., professor of radiology
and chief of pediatric
radiology, and Alan E.
Schlesinger, M.D., assistant
professor of radiology, as
invited participants, attended
the American College of
Radiology Videodisc Team,
February 10 -12, in Los
Angeles. The videodisc contains several thousand cases,
covering all aspects of pediatric radiology. McAlister
and Schlesinger developed
segments on gastrointestinal
tract, liver, spleen, and pancreas. The ACR plans to
offer the videodisc for sale in
late 1994 or 1995. The disc
material is geared for senior
residents studying for
Boards, for pediatric radiologists taking the Certificate of
Added Qualifications Examination, and for any practicing radiologist who wants to
use the videodisc format to
learn more about pediatric
radiology.

Bruce L. McClennan, M.D.,
professor of radiology and
chief of abdominal radiology,
collaborated on the development of an American College I
of Radiology video on the
mistaken use of ionic contrast agent for myelography.
The tape will be sent to all
radiologists and to all hospitals where myeolography is
performed.
Carlos A. Perez, M.D., professor of radiology and director of the Radiation
Oncology Center, received
the 1993 Distinguished Alumnus Award from M.D. Anderson Cancer Center, Houston,
where he completed a radiation therapy fellowship in
1964. At the award ceremonies on October 1, Perez
spoke on "Carcinoma of the
Uterine Cervix: Past, Present, and Future."

Special Presentation
R. Gilbert Jost, M.D.,
"Wide Band Networks: Their
Importance for Radiology."

FILM INTERPRETATION SESSION
L. Santiago Medina, M.D.,
first place award.
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j FELLOWSHIPS/
GRANTS
Joseph L. Roti Roti,
Ph.D., professor of radiology, associate director of
the Radiation Oncology Center, and chief of the cancer
biology section, as principal
investigator, received a $2.4
million grant from the
Motorola Corporation for
"Research on the Biological
Effects of Non-ionizing Electromagnetic Radiation."
Coinvestigators are Michael

A. Mackey, Ph.D., assistant
professor of radiology, and
Eduardo G. Moros, Ph.D.,
assistant professor of radiology and chief of hyperthermia physics service.
Marilyn J. Siegel, M.D.,
professor of radiology,
received a $249,728 National
Cancer Institute grant for the
study of RDOG IV - pediatric
solid tumors.

APPOINTMENTS/
ELECTIONS
R. Gilbert Jost, M.D., professor of radiology and chief
of the Division of Diagnostic
Radiology, was again named
one of three organizers of
Medical Imaging 1994, held
February 13 -18 in Newport
Beach with more than 1,000
attendees. The Society of
Photo-Optical Instrumentation Engineers annual symposium comprises six
separate digital imaging conferences. Jost also chaired
and organized one of the
symposium's four-day conferences — "PACS: Design
and Evaluation."
Eric Klein, M.S., instructor
in radiology, was elected to a
two-year term (1994-1996)
on the Board of Directors of
the American Association of
Physicists in Medicine
(AAPM). He was named to
the AAPM's Training of Radiologists Committee for 19941996.
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Ali S. Meigooni, Ph.D.,
assistant professor of radiology, was appointed to the
American Association of
Physicists in Medicine
(AAPM) Radiochromic Film
Dosimetry Task Group 55.
He was named to the faculty
of the 1994 AAPM Summer
School to be held at the University of California, San
Diego.

CALENDAR
April 9 - 13, 1994
American Society of Emergency Radiology
Orlando
April 24 - 29, 1994
94th Annual Meeting of the
American Roentgen Ray
Society
New Orleans
June 5 - 8, 1994
Society of Nuclear Medicine
Annual Meeting
Orlando
June 12 - 15, 1994
Computer Applications in
Radiology
Winston-Salem
June 14 - 18, 1994
American College of Medical
Physicists Annual Meeting
Jackson Hole
July 24 - 28, 1994
American Association of
Physicists in Medicine
Annual Meeting
Anaheim

Joel S. Perlmutter, M.D.,
associate professor of neurology and radiology, was
appointed chairman of the
External Review Committee
to Evaluate the Intramural
Neuroimaging Program at
the National Institute of
Mental Health.
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The MIR
Reception at
the Annual
Meeting of RSNA
1 Michel Ter-Pocossian, Ph.D„ and
Anica JovanovR, M.D., who was
MIR's first female resident.
2 (left to right) Jeff Micbalski,
M.D.; Robert Kuske, M,D.; and
Joseph Simpson, M.D., Ph.D.
3 (left to right) Robert Koehler,
M.D.; Helen Totty; Ellen Vannier;
and Michael Vannier, M.D.
4 (left to right) Jonas Singer, M.O.;
Juan Taveras, M.D.; Ronald Evens,
M.D.; Meredith Ragsdale; and
Edward Ragsdale, M.O.
5 (left to right) Ben Mayes, M.D.;
John Armstrong, MA, M.D.; Ellen
Mayes; and Jim Winthrop, M.D.

.-

6 (left to right) L Santiago Medina,
M.D.; Edda Quintero, M.D.; Lee Fox,
Washington University School of
Medicine student; and Louis Gilula,
M.D.
7 (left to right) Bruce Bower, M.D.,
1988-89 cochief resident; William

5

Horstman, M.D., 1991-92 cocMef
resident; and Michael Katz, M.D.
8 Patti Lester; Pat Lester, M.D.;
Ronald Evens, M.D.; Hanna Evens;
Robert Stanley, M.D.; and Sally
Stanley.
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Daniel Keleti, M.D., (left) and James V. Piephoff, M.D., are the 1993-1994 tochief
and chief resident, respectively, of the Radiation Oncology Center.
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